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The plasma membrane H+-ATPase (Pma1) is essential for yeast growth and is 
activated by glucose metabolism by an unknown mechanism involving double 
phosphorylation of a regulatory site at the C-terminus (Ser911 Thr912). In this thesis we 
have investigated in Saccharomyces cerevisiae the role of two protein phosphatases, 
type 1 Glc7 and type 2A Sit4, and of an essential atypical protein kinase, TORC1, in the 
activation of Pma1 by glucose. The regulatory site of activated Pma1 can be 
dephosphorylated “in vitro” by recombinant Glc7 and Sit4, but inhibition “in vivo” of 
these phosphatases does not activate Pma1. Inhibition of Glc7 by regulated expression 
of a dominant-negative truncated form (the null mutant is not viable) had no effect on 
Pma1 activity while deletion of SIT4 gene decreased both Pma1 activity and double 
phosphorylation of the regulatory site. Inhibition of TORC1 protein kinase by treatment 
of yeast cells with the drug rapamycin or by exposure to non-permissive temperature of 
a temperature-sensitive mutant (tor1Δ tor2ts) inhibited Pma1 and decreased double 
phosphorylation of the regulatory site. We conclude that Sit4 and TORC1 are required 
for full activation of Pma1 by glucose while Glc7 either does not participate or is 




 La H+-ATPasa de la membrana plasmática (Pma1) es esencial para el 
crecimiento de la levadura y se activa por metabolismo de glucosa por un mecanismo 
desconocido que lleva consigo la doble fosforilación de un sitio regulador en el extremo 
C-terminal (Ser911 Thr912). En la presente tesis hemos investigado en Saccharomyces 
cerevisiae la participación de dos proteína fosfatasas, Glc7 de tipo 1 y Sit4 de tipo 2A, y 
de una proteína kinasa atípica esencial, TORC1, en la activación de Pma1 por glucosa. 
El sitio regulador de Pma1 en su estado activo puede defosforilarse “in vitro” por Glc7 
y Sit4 recombinantes pero la inhibición “in vivo” de estas fosfatasas no activa Pma1. La 
inhibición de Glc7 mediante la expresión regulada de una forma truncada que actúa 
como dominante-negativa (el mutante nulo no es viable) no tiene efecto en la actividad 
de Pma1 mientras que la deleción del gen SIT4 disminuye tanto la actividad de Pma1 
como la doble fosforilación del sitio regulador. Inhibición de la proteína kinasa TORC1 
mediante tratamiento de las células de levadura con el fármaco rapamicina o 
exponiéndolas a temperatura no permisiva en el caso de un mutante termosensible 
(tor1Δ tor2ts) resulta en inhibición de Pma1 y disminución de la doble fosforilación del 
sitio regulador. Estos resultados indican que Sit4 y TORC1 son necesarias para la 
máxima activación de Pma1 por glucosa mientras que Glc7 podría no participar o 
















L’H+-ATPasa de la membrana plasmàtica (Pma1) és essencial per al creixement dels 
llevats i s’activa gràcies al metabolisme de glucosa per un mecanisme desconegut que 
porta associat la doble fosforilació d’una regió reguladora a l’extrem C-terminal 
(Ser911 Thr912). En aquesta tesi hem investigat en Saccharomyces cerevisiae la 
participació de dos proteïnes fosfatases, Glc7 de tipus 1 i Sit4 de tipus 2A, i d’una 
proteïna quinasa essencial atípica, TORC1, en l’activació de Pma1 per glucosa. La regió 
reguladora de Pma1, en seu estat activat, pot desfosforar-se “in vitro” per Glc7 i Sit4 
recombinants, però la inhibició “in vivo”  d’aquestes fosfatases no activa Pma1. La 
inhibició de Glc7 mitjançant l’expressió regulada d’una forma truncada que actua com a 
dominant-negativa (el mutant nul no és viable) no té cap efecte en l’activitat de Pma1 
mentre que la deleció del gen SIT4 disminueix tant l’activitat de Pma1 com la doble 
fosforilació de la regió reguladora. La inhibició de la proteïna quinasa TORC mitjançant 
un tractament de cèl·lules de llevat amb el fàrmac rapamicina o la seua exposició a 
temperatures no permissives en el cas d’un mutant termosensible (tor1Δ tor2ts) resulta 
en la inhibició de Pma1 i la disminució de la doble fosforilació de la regió reguladora. 
Aquests resultats indiquen que Sit4 i TORC1 són necessàries per a l’activació màxima 
de Pma1 per glucosa, mentre que Glc7 podria no participar o fer-ho d’una forma 
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                                        INTRODUCTION                                    
Plasma membrane H+-ATPase (Pma1) is an extremely important enzyme for 
yeast cell growth and metabolism and on the other hand it is a very expensive one in 
terms of ATP consumption, which makes its regulation a vitally important subject. Until 
now complete understanding of Pma1 regulation is not accomplished and the systems 
that modulate the activity of Pma1 remain largely unknown. Knowing that almost all 
eukaryotic proteins are regulated by phosphatases and kinases, in this thesis we have 
tested two major protein phosphatases and one protein kinase of yeast cells for their 
possible role in regulation of Pma1. 
 
Plasma membrane H+-ATPase 
 The yeast plasma membrane H+-ATPase (in the following “Pma1”) is a proton 
pump that plays a crucial role in the physiology of Saccharomyces cerevisiae (in the 
following “yeast”) (Serrano, 1985). It is encoded by PMA1 gene (YGL008c) and 
composed of a polypeptide of about 100 kDa (Serrano, 1985; Serrano et al., 1986). 
There is another Pma1 gene, PMA2, but it is expressed at very low levels and is not 
essential for growth (Schlesser et al., 1988). As indicated in Figure 1, Pma1 energizes 
the plasma membrane by generating an electrical membrane potential (positive outside) 
and a pH gradient (acid outside) to drive active nutrient influx and sodium efflux. It also 
regulates intracellular (pHi) and extracellular pH for yeast growth and external 
acidification, respectively (Serrano, 1985 and 1991). Pma1 is a major transport system, 
accounting for 25-50% of yeast plasma membrane protein (Serrano, 1991) and 
consuming 15-50% of the ATP produced in yeast cells (Gancedo and Serrano, 1988).  
 Changes in pHi are of high importance to control the cell growth and 
proliferation and rates of DNA and RNA synthesis appear to increase with higher pHi 
within the normal physiological range (Nuccitelli and Deamer, 1982). Also, key 
glycolytic enzymes are believed to be regulated by pHi, particularly 
phosphofructokinase (Holyoak et al., 1996). Accordingly, the PMA1 gene is essential 
for yeast life (Serrano et al., 1986) and there is an impressive correlation between the 
activity of the enzyme and yeast growth (Portillo and Serrano, 1989; Vallejo and 
Serrano, 1989). Finally, the electrical membrane potential of yeast plasma membranes, 
negative inside, drives the uptake of toxic cations such as sodium, lithium, 
aminoglycosides and polyamines and it is set by the relative activities of Pma1 and of 
the major potassium uptake system Trk1 (see Figure 2 and Goossens et al., 2000). 
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Figure 1. Scheme of ion homeostasis in yeast. The proton pumping H+-ATPase Pma1 utilizes the energy 
of ATP hydrolysis to pump protons out of the cell. This generates a pH gradient, acid outside, and a 
membrane potential, positive outside. Both components of the electrochemical proton gradient drive 
nutrient uptake and extrusion of sodium and anions. The vacuolar H+-ATPase (VMA) energizes the 
vacuolar membrane by generating a pH gradient (acid inside) and a membrane potential (positive inside). 





Figure 2. Model for the role of Pma1 and Trk1, 2 on yeast  tolerance to toxic cations by modulation of 
the electrical membrane potential (ΔΨ), which determines the uptake of toxic cations by different 




























doing modulates the activity of secondary active transport sys-
tems such as those involved in nutrient and toxic cation uptake.
In addition, the Pma1 and Trk1,2 systems modulate important
biophysical parameters, such as internal and external pH, cell
turgor, and intracellular K! concentrations. Therefore, the
regulation of major determinants of ion homeostasis such as
Pma1 and Trk1,2 is crucial for cell metabolism and growth and
for the sensitivity to toxic cations. Although the absolute values
of the yeast plasma membrane potential cannot be measured
by electrophysiological methods (28), a series of indirect mea-
surements indicate that this biophysical parameter correlates
with the uptake of cations such as hygromycin B, methylam-
monium, and tetraphenylphosphonium (28, 33, 38, 57).
Mutations of the Pma1 ATPase which decrease the electro-
genic activity of the enzyme cause the same pleiotropic growth
phenotypes of tolerance to toxic cations as the ptk2 mutations
described in the present work (38, 56, 62). It would be inter-
esting to determine the causal relationship between the differ-
ent mutations affecting the activity of Pma1 and the different
growth phenotypes exhibited by cells. As a tentative interpre-
tation, the electrogenic activity of the proton pump, modified
by either mutation or altered phosphorylation, would set dif-
ferent levels of the electrical membrane potential (Fig. 7).
Cation transporters would then exhibit a differential response
according to their specific voltage sensitivities. The different
phenotypes of YOR267c and Ptk2 protein kinase mutants, as
well as the different phenotypes exhibited by pma1 mutants
(31), may be explained by their different levels of proton-
pumping activity. Additional complications include the fact
that decreased activity of the plasma membrane ATPase some-
how enhances vacuolar compartmentation of toxic cations (34).
Npr1, the founding member of a subfamily of yeast protein
kinases, regulates the activity and stability of the amino acid
permeases Gap1 and Tat2 in response to ammonium availabil-
ity, probably by direct phosphorylation of these membrane
proteins (47). We have previously described two redundant
protein kinases of the Npr1 subfamily (Hal4 and Hal5) which
regulate Trk1,2, the major high-affinity K! transport system of
yeast, in response to K! starvation (33). Now we report that
another member of the Npr1 group, Ptk2, regulates the yeast
proton pump Pma1 in response to glucose metabolism. In
addition, two other protein kinases of the Npr1 group, Ptk1
and YOR267c, seem to modulate Pma1. Ptk1 is highly homol-
ogous to Ptk2, and its gene was discovered as a multicopy
suppressor of the polyamine uptake defect of ptk2 mutants
(25). Disruption of ptk1 causes no growth or Pma1 activity
phenotype (F. Portillo, unpublished results). It could corre-
spond to a protein kinase similar in function to but less active
than Ptk2. Although YOR267c is much more related to Npr1
than to Ptk2, it also regulates Pma1 activity. However, the
growth phenotypes of gain and loss of function for this kinase
are restricted to hygromycin B, and we propose to rename
YOR267c HRK1, for hygromycin resistance kinase. According
to the model developed above, the unknown transporter for
hygromycin B may be more sensitive than other cation trans-
porters to the small changes in membrane potential deter-
mined by the YOR267c mutations. Finally, Npr1 itself seems
to regulate ion homeostasis, because although its disruption
has no significant effect on Pma1 activity (F. Portillo, unpub-
lished results), it reduces polyamine transport (27) and slightly
increases sodium tolerance (S. Kron, personal communica-
tion), as if this kinase also contributed to Pma1 activity.
The emerging picture is that yeast cells contain a subfamily
of protein kinases which are dedicated to the regulation of
plasma membrane transporters and which may exhibit some
promiscuity. Ptk2 and Hal4,5 are the major regulators of Pma1
and Trk1,2, respectively, while Npr1 modulates the amino acid
transporters Gap1 and Tat2, although it may also act on Pma1,
together with less active kinases such as Ptk1 and Hrk1. The
specificity of these protein kinases is unknown, and it remains
to be demonstrated at the biochemical level that they act di-
rectly on the Pma1 protein and other transporters, because the
observed effects could be indirect. The existence of kinase
cascades dedicated to ion homeostasis is plausible, and the
signalling pathways should have sensors of basic cellular pa-
rameters such as energy metabolism, membrane potential, pH,
K! concentration, and turgor. These mechanisms, and the
nature of the protein phosphatases counteracting the activat-
ing kinases, are currently under investigation.
The glucose-induced affinity change of the ATPase requires,
in addition to the protein kinase Ptk2, the ubiquitin-protein
ligase Rsp5 (8), suggesting that the turnover of some protein(s)
is also important for the regulation of the ATPase. The glu-
cose-induced increase in the Vmax of the ATPase depends on
Arg-909 and Thr-912, which define a potential phosphorylation
site for calmodulin-dependent protein kinase II. However, mu-
tational analysis has indicated that the mechanism of Vmax
regulation is more complex than simple phosphorylation (12)
and involves the membrane protein YOR137c (9) and the
small heat shock protein Hsp30 (4). Other pieces of the puzzle
of ion homeostasis in yeast include the calcium-regulated pro-
tein phosphatase calcineurin, which regulates both Trk1,2 and
the ATPase (62), and, as demonstrated in fission yeast, some
type I protein phosphatases and mitogen-activated protein
kinases (2).
Ptk2 (present work) and Hal4,5 (33) represent the first pro-
tein kinases which modulate the major electrogenic transport-
ers of yeast cells (Fig. 7). Future studies should help to convert
this glimpse of the mechanisms of ion homeostasis into a de-
tailed picture of the complex network of signaling pathways
which, since early times of evolution, were probably needed to
adjust the basic biophysical parameters of cells in response to
growth and environmental changes (21, 53). As the modulation
of membrane potential is crucial for the uptake of toxic cations
(Fig. 7), it may be part of the cellular responses to salt stress.
The recent identification of a conserved proteolipid which
seems to depolarize the plasma membrane (35) and which is
induced in plants by salt stress (5) supports this hypothesis.
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 From an applied point of view, growth of yeasts in the presence of weak-acid 
preservatives is a major concern in the food industry. It is well known that the principal 
inhibitory mode of action of these preservatives is to lower pHi, causing growth arrest 
and cell death. Despite the presence of the maximum permitted level of preservative and 
good manufacturing practice, yeast and mold spoilage still happens. Actually, the 
resistance of the spoilage yeast Zygosaccharomyces bailii to such preservatives has 
become a huge problem to the food industry in products, which rely on low pH and 
weak acids for preservation. Mechanisms of resistance to weak organic acids seem to 
involve increased activity of either Pma1 or Trk1 (Holyoak et al., 1996). The concerted 
activity of the two systems modulating pHi is needed for electrical balance during 
proton efflux (see Figures 1 and 2). 
 
We will make a brief introduction to cellular ion pumps before describing the regulation 
of Pma1, which constitutes the subject of this thesis. 
 
 Types of ion pumps 
          As indicated in Figure 3, living cells must maintain a set of major ion 
concentrations in the cytosol for proper operation of cellular systems despite variable 
external concentrations. In the course of evolution cells developed ion pumps to 
energize the membranes and maintain intracellular ion homeostasis (Maloney and 
Wilson, 1985). In addition to pumps energized by light and by red-ox reactions, ion-
pumping ATPases of two major kinds (Figure 4) were developed by ancestor cells, 
more than 2 x 109 years ago: the P-ATPases (also called E1E2-ATPases) and the rotary 
ATPases (also called FoF1, AoA1 or VoV1-ATPases). The rotary ATPases are present in 
bacteria and derived mitochondria and chloroplasts (FoF1), archaea (AoA1) and vacuolar 
or lysosomal membranes (VoV1). These are very complex reversible enzymes with 
many subunits (up to 20) and structured into a membrane embedded domain (Xo; 
involved in transport of H+ and more rarely of Na+) and a membrane-protruding domain 
(X1; catalyzing ATP hydrolysis or synthesis). The atomic structure and mechanism of 
these enzymes has been determined and the name of this type of pumps makes reference 
to their operation as a rotary motor (see the schematic drawing of Figure 5), with a 
central rotor within a surrounding stator. Rotation of the proton-binding site changes the  
accessibility of the site to the two sides of the membrane mediated by two half-channels 
in the transmembrane part of the stator (Muench et al, 2011). 
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Figure 3. Scheme of cellular ion homeostasis in most living cells. The cytosol must maintain a set of 
major ion concentrations for the proper operation of cellular machineries despite variable external 
concentrations. K+ is the major cation but Mg2+ and Ca2+ also play important roles. Na+ and H+ are toxic 





Figure 4. Types of ion pumps in living cells. Within the ATPases the so called ABC are not typical ion 
pumps and can transport many different molecules. 
 
 
The four kinds of ion pumps 
(primary active transport, chemiosmotic systems)  
Energy   Transported ion    Pump 
----------------------------------------------------------------- 
Light   H+ (Na+)     Bacteriorhodopsin 
Red-ox   H+ (Na+)     Red-ox chains in mitochondria  
         and chloroplasts 
PPi    H+ (Na+)     Pyrophosphatases from bacteria 
         and plants 
ATP   H+ (Na+)     Rotary ATPases from bacteria, 
         mitochondria, chloroplast and 
         vacuoles of eukaryotes 
   H+, Na+/K+, H+/K+        P-ATPases of bacteria and plasma and 
   Ca2+/H+, Mg2+, Cu2+   endoplasmic membranes of eukaryotes 
           
   Different compounds   ABC-ATPases   
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Figure 5. Schematic structure of rotary ion-pumping ATPases  (Modified from Muench et al., 2011). Part 
(a) indicates the complex structure of these pumps and part (b) the division into stator and rotor pieces. 
 
P-type ion-pumping ATPases 
 Pma1 belongs to the P-type ion-pumping ATPases, a versatile family of 
enzymes made of a single subunit and with different members pumping H+, Na+, K+, 
Ca2+, Mg2+ and Cu2+ (Axelsen and Palmgren, 1998; Kühlbrandt, 2004). The family is 
termed P-type because the mechanism of transport involves direct phosphorylation of a 
conserved aspartyl residue by ATP followed by hydrolysis of this aspartyl phosphate 
intermediate as a necessary part of the transport cycle. This has not to be confused with 
regulatory phosphorylations on serine and threonines by protein kinases acting on 
regulatory sites. More than 50 members of this class of membrane transport proteins 
have been sequenced and the family has been divided into five distinct classes based on 
their sequence, ion specificity and biological occurrence (Axelsen and Palmgren, 1988; 
Green, 1992). P-type ATPases are present in all species from bacteria to mammals but 
in fungi and plants the dominant plasma membrane ATPases are P-type proton pumps 
(H+-ATPases) while in animal cells a P-type Na+/K+-ATPase is the dominant pump 
(Serrano, 1985). Also, the H+-ATPases of yeast and other fungi do not contain a 
glycosylated β-subunit that is found in mammalian Na+/K+ and H+/K+-ATPases 
(Lutsenko and Kaplan, 1995). All P-ATPases have a catalytic mechanism based in four 
conformational states of the enzyme and a model based on the insight of William P. 
Jencks (1989) is shown in Figure 6. These are “linear” motors whose structure has been 
determined at the atomic level in some cases (Bublitz et al., 2010), including the plant 
proton pump that is highly homologous to yeast Pma1 (Pedersen et al., 2007). A 
representation of various structures of P-ATPases is shown in Figure 7. 
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Figure 6. The catalytic cycle of P-ATPases. The cycle for a generic enzyme pumping cation “B” out of 
the cell and cation “C” into the cells is shown. Yeast Pma1 only pumps protons (B = H+) out. After 
binding “B” from the cytosolic side (side 1), the enzyme acts as an “auto-kinase” (E1) and phosphorylates 
himself at the catalytic site, making a covalent phosphorylated intermediate (aspartyl-phosphate; E-P). 
This has not to be confused with regulatory phosphorylations on serine and threonines by protein kinases 
acting on regulatory sites. This auto-phosphorylation triggers a conformational change that shifts the 
sideness and specificity of the cation binding site, now exposed to side 2 (outside the cell) and with 
decreased affinity for cation B to exchange “B” by “C”. Binding of the latter cation then determines a 
new catalytic activity as an auto-phosphatase (E2), releasing the phosphate (Pi) from E-P. This again 
triggers a conformational change that shifts the sideness and specificity of the cation binding site to side 1 
(inside the cell) and exchange of “C” by “B”, completing the cycle. After Jencks (1989). 
 
 
Figure 7. Schematic structure of several P-ATPases in different conformations. Ca2+/H+-ATPase from 
sarcoplasmic reticulum (Serca), Na+/K+-ATPase and H+/K+-ATPase from mammalian plasma membranes 
and H+-ATPase from plant plasma membranes. Modified from Bublitz et al., (2010). The upper part 
represents the overall structure of different P-ATPases by α-helices and β-sheets. The lower part 
represents the transmembrane helices with the cation binding sites. The accessibility of these sites to the 
two sides of the membrane and their affinity changes depending on the auto-phosphorylation of the 
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Regulation of Pma1 activity   
           The regulation of Pma1 activity was shown for the first time by Serrano (1983), 
who discovered that incubation of yeast cells with glucose resulted in a reversible 
several-fold enhancement of the enzyme’s activity, a decrease in Km, and an increase in 
Vmax.  Sugars utilized by the glycolytic pathway (glucose, fructose and mannose) were 
shown to lead to the enhancement of activity. Sugars metabolized through other 
pathways (galactose), as well as non-metabolized glucose analogs (xylose, 3-O- 
methylglucose and deoxyglucose), did not result in any enhancement (Serrano, 1983). 
             Concerning regulation of expression, glucose metabolism, through the 
Rap1/TUF and Gcr1 transcription factors, increases the expression of the PMA1 gene 
together with that of genes of glycolytic enzymes, ribosomal proteins and translation 
factors, all of them important for fast growth in glucose medium (Capieaux et al., 1989; 
Portillo, 2000). However, this transcriptional regulation of Pma1 is relatively small, less 
than 2-fold, and regulation occurs mostly at the level of activity, not amount of the 
enzyme (Portillo, 2000). In other words, regulation of Pma1 is mostly due to 
posttranslational modification. Pma1 activity is increased by conditions that stimulate 
yeast growth, such as good carbon sources like glucose (Serrano, 1983) and by stress 
conditions that can be alleviated by the activity of the enzyme, such as intracellular 
acidification induced by low external pH (Eraso and Gancedo, 1987), nitrogen 
starvation (Benito et al., 1992) and supraoptimal growth temperature (Viegas et al., 
1995). In the case of glucose the activation of proton pumping is much greater than the 
activation of ATP hydrolysis because it increases the number of protons pumped per 
ATP hydrolyzed (Venema and Palmgren, 1995). The activation by glucose requires 
metabolism of the sugar and it is independent of the plasma membrane glucose 
receptors Snf3/Rgt2 and Gpr1 (Belinchón and Gancedo, 2007). 
 The regulation of Pma1 activity by glucose metabolism and acidification 
described above depends on a regulatory domain of Pma1 present at the C-terminus of 
the enzyme (Benito et al., 1992). In the scheme of Figure 8 it is shown the domain 
structure of Pma1 and at the C-terminus is the regulatory domain identified by deletion 
analysis of the enzyme (Portillo et al., 1989; Serrano and Portillo, 1990). The last 21 
amino acids of this domain (from Arg898 to Thr918) mediate the activation of the 
enzyme by glucose metabolism and by acidification.  
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Figure 8. Model for the domain structure of yeast Pma1. The ten transmembrane helices and the 
conserved motifs I to VI of P-ATPases are indicated. Motif I (TGES) is the active site of the auto-
phosphatase domain, motif II (D[K,R]TGT[L,I]T) include the aspartate (D) auto-phosphorylated in the 
reaction intermediate and motifs III (KGAP), IV (DPPR), V (M[L,I,V]TGD) and VI (GDGXND) are 
involved in ATP binding for the auto-kinase reaction. From Serrano and Portillo (1990). The regulatory 
domain is at the C-terminus of the enzyme and is not conserved in different types of P-ATPases. Its 















Properties of mutants of  yeast plasma membrane H + -,4 TPase 
(A) Mutations decreasing activity and phosphorylation to a similar extent 
(kinase reaction affected) 
Amino acid ATPase activity G T P / A T P  ratio 
change a (wild type = 100) (wild type = 0.15) 
Cys376-Leu (II) 65 0.15 
Lys379-Gln (II) 70 0.15 
Lys474-Gln (III) < 5 
Lys474-Arg (III) 30 0.15 
Lys474-His (III) 10 0.15 
Asp534-Asn (IV) 10 1.6 
Asp560-Asn (V) 5 3.0 
Asp638-Asn (VI) 5 4.0 
(B) Mutations affecting hydrolysis of the phosphorylated intermediate 
( E -  P, phosphatase reaction affected) 
Amino acid change a ATPase Turnover and level of 
activity E - P  intermediate b 
(wild type 
= 100) 
Asp226-Asn (near I) 95 decreased level 
Thr231-Gly (I) 50 greatly increased level 
Glu233-Gln (I) 30 no turnover, increased level 
Asp634-Asn (VI) 15 slow turnover, increased level 
Asp730-Asn (6) < 5 increased level 
(C) Mutations affecting vanadate sensitivity (phosphatase inhibitor) 
Amino acid ATPase activity K i for vanadate (#M) 
change a (wild type = 100) (wild type = 1/~M) 
Thr231-Gly (I) 50 > 30 
Cys376-Leu (II) 65 5 
Asp378-Asn (II) 80 0.2 
Asp378-Glu (II) 100 0.2 
Asp378-Thr (II) 80 0.3 
Lys379-Gln (II) 70 0.3 
Asp634-Asn (VI) 15 10 
(D) Mutations decreasing H + transport more than A TPase activity 
(uncoupled) 
Amino acid change a ATPase activity H + transport 
(wild type = 100) (wild type = 100) 
Asp226-Asn (near I) 95 65 
Glu233-GIn (I) 30 15 
Ser234-Ala (I) 350 80 
Pro335-Ala (4) 70 40 
Asp378-Glu (II) 100 35 
Asp378-Thr (II) 80 15 
(E) Mutations affecting the regulation of  the A TPase by glucose metabo- 
lism 
Amino acid change a ATPase activity c 
(~tmol/min per mg protein) 
cells in water cells with glucose 
Wild type 0.15 
Aia547-Val (IV-V) 0.65 
Gln908-stop (C-term) 0.75 





TABLE I (continued) 
(F) Mutations affecting the level of A TPase in the plasma membrane 
Amino acids changes a which produce small decrease (40-60%): 
Asp200-Asn (near I), Glu233-Gln (I), Pro335-Ala (4), Asp378- 
Glu (II), Asp378-Thr (II), Lys474-Gln (III), Asp534-Asn (IV), 
Asp560-Asn (V), Asp638-Asn (VI) 
Amino acids changes a which produce great decrease ( > 90%): 
Ser61-initial Met (N-term), Glu 847-stop (9-10) 
(G) Mutations without noticeable effects 
Amino acid changes a: 
Lys28-initial Met (N-term), Glu129-Gln or Leu (1), Asp143-Asn 
(2), Ser 228-Ala (near I), Arg271-Thr (near I), Glu703-Gln (5), 
Glu803-Gln (8), Asn848-Asp (9-10), Ser911-Ala (C-term) 
a Conserved motif (I to VI) or predicted transmembrane helix (1 to 
10) between brackets. 
b Level of E - P  intermediate relative to ATPase activity; turnover 
after labeling with [y-32P]ATP and chase with nonradioactive ATP. 
c Assayed in purified plasma membranes at pH 7 and 2 mM ATP. 
A conserved motif of six acidic amino acids at the 
N-terminus and all the hydrophobic stretches at the 
C-terminus are essential for the assembly of the ATPase 
into the plasma membrane [6]. 
Fig. 5 summarizes our working hypothesis about the 
catalytic mechanism of the ATPase reaction. In the 
kinase-active conformation (E 1) ATP binds through the 
PHOSPHORYLATION AND 
TRANSDUCTION DOMAIN 




Fig. 4. Model for the domain structure of yeast plasma membrane 
H+-ATPase. The length of the bar representing the polypeptide chain 
i  approxi ately proportional to the number of amino acid  in every 
domain. The open parts of the bar correspond to the conserved 
regions A - E  of Fig. 1 and the conserved motifs I -VI  are also 
indicated. The transmembran  helices correspond to the hydrophobic- 
ity peaks 1-10 of Fig. 2. 
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The suggested mechanism (Portillo, 2000) is that this regulatory domain in the inactive 
state blocks the binding to the enzyme of both the transported proton and ATP. Upon 
some modification induced by glucose metabolism or acidification the regulatory 
domain is displaced and allows access of both proton and ATP to the enzyme (Figure 
9).  
 In the case of activation by glucose metabolism this modification has been 
shown to correspond to phosphorylation of two sites: Ser899 and double 
phosphorylation at Ser911 and Thr912. The sequence of the regulatory domain is shown 
in Figure 10, with the two phosphorylation sites important for activation by glucose 
metabolism indicated. Although an inhibitory phosphorylation of Ser507 (within the 
kinase domain) by casein kinase I (Yck1) has been described, this site has a minor 
effect on the activation by glucose of Pma1 (Estrada et al., 1996). Phosphorylation of 
Ser899 by protein kinase Ptk2 slightly activates Pma1 by improving the affinity of the 
enzyme for ATP (Eraso and Portillo, 1994; Goossens et al., 2000, Eraso et al., 2006). 
However, the most important regulation of Pma1 by glucose metabolism is mediated by 
double phosphorylation of Ser911 and Thr912, which greatly affects the maximal rate 
of the enzyme (Portillo et al., 1991; Lecchi et al., 2007). As Ser911 is phosphorylated in 
the absence of glucose (Lecchi et al., 2007), the phosphorylation of Thr912 is the 
crucial modification of Pma1 during activation by glucose metabolism.  
 At present the protein kinases phosphorylating Pma1 at Thr912 in response to 
glucose metabolism remains unknown. A scheme of the regulatory pathways triggered 
by glucose in yeast is shown in Figure 11 (modified from Belinchón and Gancedo, 
2007). A major yeast protein kinase activated by glucose, protein kinase A, is not 
involved in glucose activation of Pma1 (Mazón et al., 1989; dos Passos et al., 1992). 
Protein kinase C and Ca2+/calmodulin-dependent protein kinases have been proposed to 
regulate Pma1 in response to glucose metabolism (Brandao et al., 1994) but a 
demonstration that these kinases phosphorylate Pma1 remains to be reported.  
            Campetelli et al., (2005) have reported that in glucose starved cell Pma1 forms a 
complex with acetylated tubulin that is disrupted when the enzyme is activated by 
glucose metabolism. This change in interaction of Pma1 with acetylated tubulin as well 
as the changes in distribution of Pma1 in the membrane surface observed by	  Permyakov 
et al., (2012) using immunoglod labeling may be structural consequences of the 
conformational changes triggered by phosphorylation of the regulatory domain of Pma1.  
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Figure 9. Model for the activation of Pma1. In the low-activity state (upper), the C-terminus would 
interact with the active site of the enzyme, limiting access of the protons and ATP substrates. The 
activators would trigger a modification of the C-terminus, releasing the inhibitory interaction and 






Figure 10. Amino acid sequence of the last 21 amino acids of Pma1. The two activating phosphorylation 
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Figure 11. The effects of glucose on different processes in yeast depend on different combinations of 
early signals. Induction of SUC2 by low glucose depends partially on the glucose sensors, and requires 
glucose metabolism; in the absence of metabolism, induction requires high glucose and is fully dependent 
on Gpr1. Induction of HXT1 requires Snf3 or Rgt2, and is partially dependent on Hxk2. Induction of 
PDC1 is independent of the glucose sensors, has some dependence on Hxk2 or Hxk1, and requires 
glucose metabolism. Repression of different genes is independent of the glucose sensors; for SUC2, 
GAL1 and GDH2, Hxk2 or Hxk1 are required, and presumably glucose metabolism; for FBP1 and ICL1, 
glucose metabolism is necessary, but any glucose-phosphorylating enzyme sustains repression. In the 
absence of glucose metabolism, phosphorylation of FbPase is impaired, and the effect is reinforced by 
lack of Gpr1; degradation of FbPase depends on glucose metabolism, and is decreased when Gpr1 is 
lacking. Activation of H+-ATPase Pma1 is independent of the glucose sensors, and has a strong 
dependence on Hxk2 or Hxk1; it is nearly blocked in the absence of glucose metabolism. The interactions 
between the initial elements of signaling and their targets are indicated by arrows; the width of the arrows 
is related to the strength of the signal, and putative interactions are indicated by dashed lines. Green color 
for induction; red, for repression; , blue for activation; grey for inactivation (by phosphorylation or 
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Protein kinases and Phosphatases 
           Regulation of protein activities by phosphorylation is one of the most important 
regulatory mechanisms in eukaryotic cells (Hanks and Hunter, 1995). The process of 
phosphorylation and dephosphorylation of a protein serves as an “on-and-off” switch in 
the regulation of cellular activities. For optimal regulation, protein kinases and 
phosphatases have to reach a balance in any given cell (Luan, 2003). A large fraction of 
eukaryotic proteins, about one-third, are controlled by phosphorylation of specific 
serine, threonine, and/or tyrosine residues (Ceulemans and Bollen, 2004). Adding or 
removing a phosphate group from a protein often has profound effects on the structure 
and thereby the functional properties of it. For example, phosphorylation can regulate 
an enzyme activity by initiation of allosteric conformational changes that may affect the 
access to its active site (Johnson and O’Reilly, 1996). The interaction among protein 
partners that must form complexes in order to function is also affected by 
phosphorylation (Pawson, 1995). Some proteins need to be phosphorylated to be able to 
target a certain destination site in the cell where they function. Almost all aspects of cell 
function involve reversible phosphorylation: metabolism, cell cycle progression, ion 
transport, developmental control, and stress responses. This diversity in cellular 
functions is reflected by the large number of intracellular proteins subjected to 
reversible phosphorylation and the large number of protein kinases and phosphatases 
that catalyze these reactions (Luan, 2003).  
           There are about a hundred protein tyrosine kinases and the same number of 
protein tyrosine phosphatases in mammalian cells. In fungi and plants tyrosine 
phosphorylation is much less important and there are only a few kinases and 
phosphatases for this modification. Concerning protein serine/threonine (Ser/Thre) 
phosphorylation, mammalian cells have about 400 protein kinases and 25 protein 
phosphatases (Plowman et al., 1999), and this suggest distinct diversification strategies 
during evolution (Ceulemans et al., 2002). At variance with mammalian cells, the yeast 
genome encodes and expresses 106 protein phosphatases (Stark, 1996) and 113 protein 
kinases (Hunter and Plowman, 1997), the number of protein kinases and phosphatases is 
similar. The true diversity of protein Ser/Thre phosphatases is only seen at the 
holoenzyme level because of the variety of regulators that can interact with a given 
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The atypical TOR protein kinase 
  There are also a few non-conventional, atypical protein kinases. These are 
enzymes more related by sequence to metabolic kinases that phosphorylate metabolites 
but behave in cells as kinases that phosphorylate proteins. One of these rare enzymes is 
TOR (Target Of Rapamycin), an atypical protein kinase sensitive to the drug rapamycin 
that plays a crucial role in nutrient signaling and growth control. It was discovered in 
yeast and is homologous to phosphatidylinositol kinases involved in lipid metabolism 
although it phosphorylates proteins at serine and threonine residues.  (Loewith and Hall, 
2011). TOR is a highly conserved protein kinase among eukaryotes but S. cerevisiae is 
unusual in having two TOR genes (TOR1 and TOR2) whereas almost all the other 
eukaryotes, including plants, worms, flies, and mammals, have a single TOR gene 
(Loewith and Hall, 2011). In yeast Tor1 and Tor2 proteins both have 282 kDa  (2470 
and 2474 amino acids, respectively) and are 67% identical. They are the founding 
members of the PIKK family of atypical Ser/Thr-specific kinases related to 
phosphatidylinositol kinases (Keith and Schreiber, 1995). Disruption of both TOR1 and 
TOR2 genes in yeast leads to growth arrest similar to that caused by rapamycin 
treatment, suggesting that Tor1 and Tor2 are the ultimate targets of rapamycin, a potent 
inhibitor of yeast growth (Kunz et al., 1993).  
 Tor1 and Tor2 have a central role in controlling yeast growth as part of two 
separate signaling branches. They are functionally different despite being structurally 
similar (Helliwell et al., 1994). Disruption of only TOR1 has little or no effect but 
disruption of TOR2 alone causes cells to arrest growth within a few generations and to 
have a randomized actin cytoskeleton (Schmidt et al., 1996). TOR2 has two essential 
functions: one function is redundant with TOR1 and the other function is unique to 
TOR2 (Helliwell et al., 1998). This is explained because Tor1 and Tor2 are found as 
part of two essential complexes, TORC1 and TORC2, conserved in eukaryotes 
(Loewith and Hall, 2011). In yeast TORC1 contains either Tor1 or Tor2 but only Tor2 
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Figure 12. Conserved domain structure of TOR. The N-terminal half of TOR is composed of two blocks 
of 20 HEAT repeats, 40 aa that form pairs of interacting antiparallel a-helices. The 500-aa FAT (FRAP-
ATM- TRRAP) domain contains modified HEAT repeats. Missense mutations in the 100-aa FRB 
(FKBP12-rapamycin-binding) domain confer complete resistance to rapamycin. The kinase domain 
phosphorylates Ser/Thr residues in protein substrates, but at the sequence level resembles the catalytic 
domain of phosphatidylinositol kinases. (B) Composition of TOR complex 1. TORC1 is 2 MDa in size 
and contains Kog1, Tco89, Lst8, and either Tor1 or Tor2. The HEAT repeats found in Kog1 and the 
seven-bladed propellers of the WD-40 repeats found in Kog1 and Lst8 are depicted. The binding of Kog1 
to TOR is complex, involving multiple domains on each protein. Lst8 binds to the kinase domain of TOR. 
Each component is likely present in two copies. (C) Composition of TOR complex 2. TORC2 is 2 MDa 
in size and contains Avo1, Avo2, Avo3, Bit61, and/or its paralog Bit2, Lst8, and Tor2 but not Tor1. The 
RasGEFN domain of Avo3 and the PH domain of Avo1 are indicated. Each component is likely present 
in two copies (Loewith and Hall, 2011). 
 
Regulation of and by TORC1  
Both TOR complexes have a dual localization, cytoplasmic and membrane-
bound, with TORC1 partially bound to the vacuolar membrane and TORC2 partially 
bound to the plasma membrane (Sturgill et al., 2008). TORC1 signaling is responsive to 
nutrients, which are mainly stored in the yeast vacuole; this makes such localization of 
TORC1 very logical (Figure 13). The EGO complex resides on the vacuolar/lysosomal 
membrane and is thought to couple amino acid signals to TORC1. It is an important 
regulator of TORC1 (Binda et al., 2009). Under inappropriate conditions of growth, 
each of which is !40 residues that form a pair of interacting
antiparallel a-helices (Andrade and Bork 1995; Perry and
Kleckner 2003). The HEAT repeats occupy the N-terminal
half of TOR and are the binding region for subunits of the
TOR complexes (Wullschleger et al. 2005) (see below).
The central FAT domain (!500 residues) and the extreme
C-terminal FATC domain (!35 residues), flanking the FRB
and kinase domains, are always paired and found in all PIKK
family members (Alarcon et al. 1999; Bosotti et al. 2000;
Dames et al. 2005). The FRB domain (!100 residues) is
the FKBP–rapamycin-binding region. All rapamycin resis-
tance-conferring TOR mutations fall within the FRB domain,
thereby directly preventing the binding of FKBP–rapamycin
without otherwise affecting TOR activity (Heitman et al.
1991a; Cafferkey et al. 1993; Helliwell et al. 1994; Stan
et al. 1994; Chen et al. 1995; Lorenz and Heitman 1995;
Choi et al. 1996). Interestingly, all the original rapamycin-
resistance conferring mutations in TOR1 and TOR2 are mis-
sense mutations confined to a single, equivalent codon
encoding a critical serine residue (Ser1972Arg or Ser1972-
Asn in TOR1 and Ser1975Ile in TOR2) (Cafferkey et al.
1993; Helliwell et al. 1994), which explains why the
rapamycin-resistance TOR mutations were rare. Recreating
an equivalent mutation (Ser2035Ile) in mammalian TOR
(mTOR) was instrumental in demonstrating that mTOR is
the target of FKBP–rapamycin in mammalian cells (Brown
et al. 1995). Thus, the early rapamycin-resistant yeast
mutants turned out to be very informative. They not only
identified TOR, but also identified the FKBP–rapamycin-
binding site in TOR and contributed to elucidating the
mechanism of action of rapamycin. The kinase domain is
the catalytic domain and resembles the kinase domain of
PI3K and PI4K lipid kinases. Despite high interest i a struc-
ture of the kinase domain, no such structure exists for any
TOR, which is likely due to technical difficulties in express-
ing this domain for structural studies. In the absence of
a true model, a homology model based o the crystal s ruc-
ture of related PI3K has been elaborated (Sturgill and Hall
2009). A number of groups have identified activating, mis-
sense mutations in S. cerevisiae and Schizosaccharomyces
pombe TORs (Reinke et al. 2006; Urano et al. 2007; Ohne
et al. 2008). These mutations fall within the FAT, FRB, and
kinase domains, and, interestingly, one of the hotspots in the
kinase domain corresponds to a region for oncogenic muta-
tions in PI3K (Sturgill and Hall 2009; Hardt et al. 2011).
In the mid-1990s, research in the TOR field focused on
elucidating the cellular roles of TOR1 and TOR2. It was
found that TOR1 and TOR2 play a central role in controlling
cell growth as part of two separate signaling branches. Al-
though structurally similar, TOR1 and TOR2 are not func-
tionally identical (Kunz et al. 1993; Helliwell et al. 1994).
Combined disruption of TOR1 and TOR2, or rapamycin
treatment, mimics nutrient deprivation including causing
a G0 growth arrest within one generation (Barbet et al.
1996). Disruption of TOR1 alone has little-to- o effect,
and disruption of TOR2 alone causes cells to arrest growth
within a few generations as small-budded cells in the G2/M
phase of the cell cycle and with a randomized actin cyto-
skeleton (Kunz et al. 1993; Helliwell et al. 1994, 1998a;
Schmidt et al. 1996). These and other findings led to the
model that TOR2 has two essential functions: one function
is redundant with TOR1 (TOR shared) and the other func-
tion is uniqu to TOR2 (TOR2 unique) (Hall 1996; Helliwell
et al. 1998a). As described below, these two TOR2 functions
turned out to be two separate signaling branches (each cor-
responding to a structurally and functionally distinct TOR
complex) that control cell growth in different ways (Barbet
et al. 1996; Schmidt et al. 1997, 1998; Bickle et al. 1998;
Helliwell et al. 1998a; Loewith et al. 2002; Loewith and Hall
Figure 1 (A) Conserved domain structure of TOR. The N-terminal half of
TOR is composed of two blocks of !20 HEAT repeats, 40 aa that form
pairs of interacting antiparallel a-helices. The !500-aa FAT (FRAP-ATM-
TRRAP) domain c ntains modified HEAT repeats. Missense utations in
the !100-aa FRB (FKBP12-rapamycin-binding) domain confer complete
resistance to rapamycin. The kinase domain phosphorylates Ser/Thr resi-
dues in protein substrates, but at the sequence level resembles the cat-
alytic domain of phosphatidylinositol kinases. The!35-aa FATC domain is
always found C-terminal to the FAT domain and is essential for kinase
activity. (B) Composition of TOR complex 1. TORC1 is !2 MDa in size and
contains Kog1, Tco89, Lst8, and either TOR1 or TOR2. The HEAT repeats
found in Kog1 and the seven-bladed propellers of the WD-40 repeats
found in Kog1 and Lst8 are depicted. The binding of Kog1 to TOR is
complex, involving multiple domains on each protein. Lst8 binds to the
kinase domain of TOR. Each component is likely present in two copies. (C)
Composition of TOR complex 2. TORC2 is !2 MDa in size and contains
Avo1, Avo2, Avo3, Bit61, and/or its paralog Bit2, Lst8, and TOR2 but not
TOR1. The RasGEFN domain of Avo3 and the PH domain of Avo1 are
indicated. Each component is likely present in two copies.
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cells enters a quiescence (G0) state in which they stop dividing, slow their metabolism, 
induce the expression of stress-responsive proteins, and accumulate energy stores.  
Genetic disruption of TORC1 or rapamycin treatment mimics starvation, (De 
Virgilio and Loewith, 2006a; Loewith and Hall, 2011). Both starvation and exposure of 
yeast cells to rapamycin result in a high drop in protein synthesis, induction of 
autophagy, and exit from the cell cycle and entrance into a quiescent G0 state (Figure 
14). The transcriptional response of yeast cells exposed to rapamycin, nutrient 
starvation, or noxious stressors is similar (Gasch and Werner-Washburne, 2002).  
TORC1 does not only respond to extracellular signals, it can sense the 
intracellular amino acids and also the outputs from distal effectors can regulate TORC1 
by feed back mechanism (Loewith and Hall, 2011). Example to this feedback, TORC1 
activity stimulates translation initiation (Wullschleger et al., 2006) and inhibiting the 
translation with cycloheximide leads to high increase in TORC1 activity in response to 
increased concentration of free amino acids in the cytoplasm (Binda et al., 2009).  
Another example of the feedback is the regulation of ribosome biogenesis; TORC1 
regulates this through two substrates, Sch9 and the transcription factor Sfp1 (Loewith 
and Hall, 2011). 
 As shown in Figure 13, one important direct substrate of yeast TORC1 is a 
protein kinase called Sch9 (Powers, 2007) this substrate gets phosphorylated by TORC1 
and becomes active as a result (Urban et al., 2007). TORC1 also regulates type 2A and 
2A-related protein phosphatases like Sit4. Zheng and Jiang (2005) showed that when 
TORC1 is active, Tap42 is phosphorylated and bound tightly to the Sit4 phosphatase. 
On the other hand, TORC1 inactivation results in Tap42 dephosphorylation and a 
weakened association with phosphatases which finally results in their activation and/or 
change in substrate preference (Yan et al., 2006).  
  As a rule, under appropriate growth conditions, TORC1 is active and its signals 
promote the accumulation of cellular mass i.e., growth, via regulation of several 
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Figure 13. The EGO complex is a major regulator of TORC1. This complex is composed of four proteins 
(in red), binds to the vacuolar membrane and activates TORC1. Activated TORC1, via its two main 
effector branches, the AGC kinase Sch9 and the Tap42-PP2A and PP2A-like protein phosphatases, 
stimulates growth by favoring anabolic processes and by antagonizing catabolic processes and stress-
response programs	  (Loewith and Hall, 2011). 
 
Figure 14. Rapamycin-sensitive yeast TORC1 (TORC1) couples growth to nutrients and stresses that are 
sensed by signaling pathways that impinge upon TORC1. TORC1-regulated processes that promote 
growth are boxed in dark blue; TORC1-regulated processes that inhibit growth are boxed in dark red. 
Arrows and bars denote positive and negative interactions, respectively, and dashed arrows and bars refer 
to potential interactions (De Virgilio and Loewith, 2006a) 
kinase activity (Kuranda et al. 2006; Reinke et al. 2006;
Wanke et al. 2008), how environmental stress signals are
transduced to TORC1 is also unclear.
The EGO complex: When environmental conditions are in-
appropriate for growth, cells stop dividing, slow their me-
tabolism, induce the expression of stress-responsive proteins,
and accumulate energy stores. This nondividing but meta-
bolically active state is known as quiescence (G0). How cells
enter into quiescence is relatively well characterized. In
contrast—and despite its medical relevance (inappropriate
exit from quiescence can lead to cancer or reactivation of
a latent infection)—how quiescent cells reinitiate growth is
poorly understood. To sh light on this process, a cl ver
screen was performed to identify mutants that are unable to
escape from rapamycin-induced growth arrest (EGO)
mutants (Dubouloz et al. 2005). This and a follow-up study
(Binda et al. 2009) identified the EGO complex as an impor-
tant regulator of TORC1.
The EGO complex is composed of four proteins: Ego1,
Ego3, Gtr1, and Gtr2 (Table 3 and Figure 2). Gtr1 and
Gtr2 are Ras-family GTPases and orthologs of the metazoan
Rag GTPases (Kim et al. 2008; Sancak et al. 2008) (Table 1).
Although they lack obvious sequence homologies, Ego1 and
Ego3 are likely the functional homologs of vertebrate p18
(LAMTOR1) and p14 + MP1 (LAMTOR2 + LAMTOR3),
respectively, which function together as the “Ragulator”
complex (Kogan et al. 2010; Sancak et al. 2010). Ragulator
and the Rags mediate amino acid sufficiency signals
to mTORC1 (reviewed in Kim and Guan 2011). Like its
mammalian counterpart, the EGO complex resides on the
vacuolar/lysosomal membrane and is thought to couple
amino acid signals to TORC1 (Binda et al. 2009). Curiously,
the Gtr1GTP Gtr2GDP combination activates TORC1 with the
nucleotide-binding status of Gtr1 seemingly dominant over
the nucleotide-binding status of Gtr2.
TORC1 activity in both metazoans and yeast appears to
be particularly responsive to glutamine (Crespo et al. 2002)
and the branched-chain amino acid leucine (Binda et al.
2009; Cohen and Hall 2009). In yeast, leucine starvation
destabilizes Gtr1-TORC1 association and causes a reduction
in Sch9 phosphorylation whereas GTP-locked Gtr1Q65L
remains bound to TORC1 and Sch9 dephosphorylation is
delayed in cells expressing this mutant (Binda et al. 2009).
Loss of Gtr1 results in reduced Sch9 phosphorylation and
slow growth whereas GDP-locked Gtr1S20L is dominant neg-
ative. When Gtr1S20L is expressed as the sole version of Gtr1,
cells are extremely sick. This near inviability is suppressed
by deletion of the TCO89 gene encoding the TORC1 subunit
Tco89. Collectively, these observations suggest that the EGO
complex can both positively and negatively regulate TORC1
activity via Tco89. The fact that the EGO complex can neg-
atively regulate TORC1 activity seems to be at odds with the
current metazoan model according to which the EGO com-
plex counterpart serves only to localize TORC1 to the vacu-
ole. Indeed, in contrast to the results obtained in metazoans,
in yeast, TORC1 appears to stably localize to the vacuolar
membrane regardless of nutrient conditions. Thus, how the
EGO complex influences TORC1 activity remains a mystery
although the crystal structure of the Gtr1–Gtr2 complex,
reported very recently, provides some mechanistic insights
(Gong et al. 2011).
Also mysterious are the mechanisms by which amino acid
sufficiency modulates Gtr1/2 guanine nucleotide loading.
Given its localization, it is tempting to postulate that the
EGO complex responds to levels of intravacuolar amino
acids, possibly via the recently described Gtr1 guanine–
nucleotide exchange factor (GEF) Vam6/Vps39 (Binda
et al. 2009). It is equally plausible, however, that this signal
s mediated by an as-yet-unidentified GTPase-activating pro-
tein (GAP) activity. Consistent with the conserved function
of the EGO/Ragulator complex, and like its yeast ortholog,
hVPS39 has been found to function positively upstream of
mTORC1 (Flinn et al. 2010).
Feedback loop/ribosome biogenesis homeostasis: Although
most recognized as a target of signals emanating from
extracellular nutrients and noxious stresses, it is becoming
increasingly apparent that TORC1 also responds to intracel-
lular cues. In addition to the sensing of intracellular amino
acids as described above, outputs from distal effectors also
regulate TORC1 in apparent feedback loops. For example,
in both yeast and mammalian cells, it is well documented
that TORC1 activity stimulates translation initiation
Figure 2 The EGO complex is a major regulator of TORC1. The EGO
complex (EGOC) is compose of four proteins: the palmitoylated and
myristolated protein Ego1, the transmembrane protein Ego3, and two
Ras-family GTPases, Gtr1 and Gtr2. Like TORC1, the EGO complex is
localized to the vacuolar membrane where it appears to sense/respond
to intracellular leucine levels and potentially to intravacuolar amino acid
levels. Vam6 has been identified as a guanine nucleotide exchange factor
for Gtr1 but no other GEFs or GAPS for this GTPase system have been
reported. In the Gtr1GTP and Gtr2GDP configuration, the EGO complex
somehow activates TORC1; the reverse conformation inactivates TORC1.
Activated TORC1, via its two main effector branches, the AGC kinase
Sch9 and the Tap42-PP2a and PP2a-like protein phosphatases, stimulates
growth by favoring anabolic processes and by antagonizing catabolic
processes and stress-response programs.
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 Rapamycin treatment elicits a high drop in protein synthesis by blocking 
translation initiation (Barbet et al., 1996).  As indicated in Figure 15 (Ashe et al., 2000) 
this regulation occurs mainly through the translation factor eIF2. Amino acid starvation 
or rapamycin treatment leads to phosphorylation of the α-subunit of eIF2 (Hinnebusch, 
2005). TORC1 signals to eIF2a through both the Sch9 and Tap42-PP2A branches. The 
only eIF2-α kinase is the conserved Gcn2 protein. Gcn2 is activated when bound to 
uncharged tRNAs that accumulate when cells are starved for an amino acid. Gcn2 
activity is also regulated by phosphorylation on Ser577. This reduces tRNA binding and, 
consequently, kinase activity. Treating cells with rapamycin elicits a rapid, Tap42-
PP2A-dependent dephosphorylation of Ser577 and, consequently, an increase in Gcn2 
activity and a reduction in translation (Cherkasova and Hinnebusch, 2003). 
 
 
Figure 15. Control of translation in S. cerevisiae by the Gcn2 and TORC1 protein kinases (Ashe et al., 
2000). 
 
In the following I will list some of the many functions of TORC1. 
• Ribosome biogenesis: TORC1 plays a central role in regulating ribosome 
biogenesis at both transcriptional and posttranscriptional levels (Loewith and Hall, 
2011). TORC1 also regulates various catalytic steps of ribosome assembly per se 
(Loewith, 2010). 
• Cell cycle/cell size: Cell growth and cell division are two distinct, yet highly 
linked processes. In yeast, cells start a new round of cell division only after reaching a 
critical size (Cook and Tyers, 2007). Poor growth conditions reduce the activity of 
TORC1 and subsequently the activities of Sfp1 and Sch9. Consequently, this would 
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decrease ribosome biogenesis, which would lower the cell-size threshold required for 
cell division. In contrast, acute inhibition of TORC1 with high concentrations of 
rapamycin leads to an arrest in G1 (Barbet et al., 1996) and a paradoxical increase in 
cell size. The increased cell size is due to swelling of the vacuole as a consequence of 
increased autophagy. 
• TORC1 promotes growth also via inhibiting the stress responses. Activation of 
stress-responsive pathways is incompatible with rapid growth, and constitutive 
activation of these pathways results in cell death (Loewith and Hall, 2011).  
• Nutrient uptake and intermediary metabolism. In response to the availability of 
different nutrients yeast cells express different permeases in order to compete with other 
microorganisms for growth. TORC1 regulates these permeases primarily via Tap42-
PP2A (Breitkreutz et al., 2010). Many nutrient and cation permeases have been 
identified as rapamycin-sensitive phosphoproteins (Huber et al., 2009). TORC1 
regulates not only permease localization but also expression (Shamji et al., 2000). One 
effect on metabolism is through affecting the Gcn4 transcription factor, which gets 
activated upon amino acid starvation (Hinnebusch, 2005). Rapamycin treatment or 
amino acid starvation results in a rapid decrease in translation initiation by 
phosphorylating the α-subunit of eIF2 which results in the repression of bulk translation 
and transcriptional induction of nearly all genes encoding amino acid biosynthetic 
enzymes (Loewith and Hall, 2011). 
• TORC1 inhibits autophagy. When cells are exposed to starvation conditions they 
express stress-responsive proteins to help them. The energy and amino acids required 
for this new synthesis are obtained by inducing autophagy. Autophagy is conserved 
across eukaryotes (Yang and Klionsky, 2010) and it refers to the different mechanisms 
by which cytoplasmic material, including proteins and lipids, is translocated to the 
vacuole and catabolized. The produced amino acids and fatty acids are, respectively, 
used to synthesize new proteins and to produce ATP.  Yeast has two different modes of 
autophagy: one is microautophagy, in which the cytoplasm is directly transferred into 
the vacuole via invaginations of the vacuolar membrane. The other mode is 
macroautophagy, which involves the “de novo” formation of double-membrane vesicles 
called autophagosomes, which encapsulate cytoplasm and then fuse with the vacuole. 
The two forms of autophagy are regulated by TORC1 (De Virgilio and Loewith, 2006b).  
• TORC1 accelerates aging: Aging is the progressive deterioration of cell, tissue 
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and organ function. The genetic or chemical inhibition of TORC1 has been 
demonstrated to increase life span in yeast (Vellai et al., 2003) mostly through the 
multiple TORC1 effector pathways (Blagosklonny and Hall, 2009). Yeast life span can 
be assayed in two ways. RLS or replicative life span is defined as a measure of the 
number of progeny that a single mother cell can produce before senescence. 
Chronological life span (CLS) is a measure of the length of time a population of yeast 
cells can remain in stationary phase and keep the ability to restart growth following 
reinoculation into fresh media. RLS increases upon TORC1 inhibition. TORC1 and 
Sch9 inhibition and also induction of macroautophagy increases both RLS and CLS 
(Madeo et al., 2010). Since TORC1, Sch9, and Gcn2 homologs are found in most 
eukaryotes, the aging pathway appears to be conserved (Kaeberlein and Kennedy, 2011).  
Regulation of and by TORC2 
The majority of Tor2, almost 90%, is in TORC2 (vs. TORC1) and that is why 
Tor2 localization studies presumably detect mainly, if not only, TORC2. As described 
above, TORC2 seems to be located both at the cytoplasm and at the plasma membrane 
(Sturgill et al., 2008). Localization at the plasma membrane is consistent with the role 
of TORC2 in controlling the actin cytoskeleton and endocytosis (Loewith and Hall, 
2011). 
TORC2 is rapamycin insensitive and its regulation is poorly characterized 
(Cybulski and Hall, 2009). There is a lack of reported evidence to support that TORC2 
is controlled by nutrients. Knockout of TORC2 does not induce a starvation-like 
phenotype, and EGO, the nutrient-sensitive complex, appears not to be affecting 
TORC2. In mammalian cells, and perhaps also in yeast cells TORC2 is activated by 
direct association with the ribosome. Such a mechanism ensures that TORC2 is active 
only in growing cells because ribosomes determine the growth capacity of a cell 
(Loewith and Hall, 2011).  
 The first described and best-characterized TORC2 readout is the actin 
cytoskeleton (Figure 16). TORC2 also regulates sphingolipid biosynthesis (Powers et 
al., 2010). Sphingolipids serve as essential structural components in lipid bilayers and 
as signaling molecules. There is a mutual antagonism between TORC2 and the stress-
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Figure 16. Signaling by TORC2. TORC2 directly phosphorylates the AGC kinase family member Ypk 
(Ypk1 and 2) and the PH domain containing protein Slm (Slm1 and -2). Downstream effectors include 
the phosphatase calcineurin, the transcription factor Crz1, and Pkc1. TORC2 controls organization of the 
actin cytoskeleton, endocytosis, sphingolipid biosynthesis, and stress-related transcription. The effector 




  In the cellular regulations by phosphorylation protein kinases have been 
considered as the controlling part, with protein phosphatases (Cohen, 1989) being 
considered as mere “reset buttons”, to put cells back in the resting state when protein 
kinases are inactivated (Ceulemans and Bollen, 2004). However, the recent discovery of 
the receptors of the plant hormone abscisic acid and its mechanism of action as 
inhibitors of protein phosphatases (Santiago et al., 2012) has shown that regulation of 
protein phosphatases can also control phosphorylation signaling cascades. More 
recently, the plasma membrane H+-ATPase of the plant Arabidopsis thaliana has been 
reported to be activated by auxin by a mechanism consisting on the inhibition of PP2C-
D phosphatases by some SAUR proteins induced by the hormone (Spartz et al., 2014). 
          Typical protein phosphatases catalyze the dephosphorylation of the hydroxyl 
group on amino acid residues and are classified into two major groups, protein Ser/Thre  
(Ser/Thr) and protein tyrosine phosphatases. There is a significant structural diversity 
inside each family generated by the presence of unique regulatory and targeting 
domains or by the attachment of regulatory subunits to the catalytic subunits. These 
enzymes have very broad substrate specificities “in vitro” and the function of these 
regulatory domains or subunits is to modulate their catalytic activity and, most 
(2000) report that part of TOR2 is also in an unknown sub-
cellular membrane fraction distinct from Golgi, vacuoles,
mitochondria, and the nucleus. Wedaman et al. (2003)
showed that TOR2 can be in the cell interior often in asso-
ciation with membrane tracks. Sturgill et al. (2008) detected
a cytoplasmic fluorescent signal in cells expressing GFP-
tagged TOR2. In conclusion, TORC2 appears to be at mul-
tiple cellular locations, the plasma membrane, and one or
possibly more other sites. A plasma membrane location is
consistent with the role of TORC2 in controlling the actin
cytoskeleton and endocytosis (see below).
Upstream of TORC2
The upstream regulation of TORC2 is poorly characterized
(Cybulski and Hall 2009). Several lines of evidence in many
different organisms indicate that nutrients regulate TORC1
(see above). On the other hand, there is no reported evidence
supporting the notion that TORC2 is controlled by nutrients.
Knockout of TORC2 does not confer a starvation-like pheno-
type, and the nutrient-sensitive EGO complex appears not to
be upstream of TORC2. Zinzalla et al. (2011) recently devised
a “reverse” suppressor screen to identify upstream regulators
of TORC2. This screen was based on the observation that
constitutively active Ypk2 (Ypk2*) suppresses the loss of via-
bility due to a TORC2 defect. Ypk2 is a protein kinase nor-
mally phosphorylated and activated by TORC2 (see below).
Zinzalla et al. (2011) screened for mutants that require Ypk2*
for viability. As predicted, this screen isolated several mutants
defective in genes encoding essential TORC2 components,
but also in the gene NIP7. Subsequent experiments confirmed
that Nip7, a ribosome maturation factor, is required for
TORC2 kinase activity. The role of Nip7 in the activation of
yeast TORC2 has so far not been pursued further, but experi-
ments in mammalian cells suggest that mNip7 is required for
mTORC2 activation indirectly via its role in ribosome matu-
ration. In mammalian cells, and presumably also in yeast
cells, TORC2 is activated by direct association with the ribo-
some. As ribosomes determine the growth capacity of a cell,
this mechanism ensures that TORC2 is active only in growing
cells.
There are also indications that environmental stress
inhibits TORC2 signaling, possibly to prevent growth in
unfavorable conditions. The mechanism of this regulation
and the level at which it intersects with the TORC2 pathway
are poorly defined, but it may involve the Slm proteins (see
below) and the stress-activated phosphatase calcineurin
(Bultynck et al. 2006; Mulet et al. 2006).
TORC2 substrates
The best-characterized and possibly the major TORC2 sub-
strate is the protein kinase Ypk. Ypk1 and Ypk2 are an es-
sential pair of homologous kinases and members of the AGC
kinase family (Roelants et al. 2004) (Figure 4). Kamada
t al. (2005) linked Ypk to TORC2 signaling upon isolating
YPK2 as a multicopy suppressor of a TORC2 defect. They
hen showed that immunopurified TOR2 directly phosphor-
ylates Ypk2 at Ser641 in the turn motif and Thr659 in the
hydrophobic motif. TORC2 phosphorylates and activates
Gad8 and SGK1, the S. pombe and mammalian orthologs
of Ypk, respectively, in a similar manner (Matsuo et al.
2003; Garcia-Martinez and Alessi 2008). It is well estab-
lished that TORC1 or TORC2 phosphorylates the turn and
hydrophobic motifs in several kinases as a conserved mech-
anism of activation of AGC kinase family members (see
above) (Jacinto and Lorberg 2008). Ypk/Gad8/SGK1
appears to be a major TORC2 substrate as an ypk, gad8, or
sgk1 mutation phenocopies a TORC2 defect, and overex-
pression of Ypk2, Gad8, or SGK1 is sufficient to suppress
a TORC2 defect in S. cerevisiae, S. pombe, or Caenorhabditis
elegans, respectively (Matsuo et al. 2003; Kamada et al.
2005; Jones et al. 2009; Soukas et al. 2009). The two ho-
mologous, TORC2- and phosphoinositide (PI4,5P2)-binding
proteins Slm1 and Slm2 have also been reported to be phos-
phorylated in a TORC2-dependent manner both in vivo and
in vitro (Audhya et al. 2004; Fadri et al. 2005). However, the
physiological relevance of Slm phosphorylation is unknown
other than that it appears to be required for localization of
Slm to the plasma membrane (Audhya et al. 2004; Fadri
et al. 2005).
Distal readouts downstream of TORC2
The first described and best-characterized TORC2 readout is
the actin cytoskeleton (Figure 4). TORC2 controls the cell
cycle-dependent polarization of the actin cytoskeleton. As
the polarized actin cytoskeleton directs the secretory path-
way and thereby newly made protein and lipid to the grow-
ing daughter bud, this is a mechanism by which TORC2
mediates spatial control of cell growth. The first indication
that TOR2 is linked to the actin cytoskeleton came from the
isolation of TCP20, which encodes an actin-specific chaper-
one, as a dosage suppressor of a dominant-negative TOR2
“kinase-dead” mutation (Schmidt et al. 1996). This, in turn,
led to the discovery that tor2 mutants display an actin
Figure 4 Signaling by TORC2. TORC2 directly phosphorylates the AGC
kin family member Ypk (Ypk1 and 2) nd the PH domain contai ng
protein Slm (Slm1 and -2). Downstream effectors include the phospha-
tase calcineurin, the transcription factor Crz1, and Pkc1. TORC2 controls
organization of the actin cytoskeleton, endocytosis, sphingolipid biosyn-
thesis, and stress-related transcription. The effector pathways by which
TORC2 controls these processes are incompletely understood (see Distal
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important, to target the catalytic subunit to a specific subcellular compartment to 
determine the “in vivo” substrate specificity of protein phosphatases (Cohen, 1989; 
Luan, 2003). 
 As indicated in Figure 17, there are two major types of protein Ser/Thr 
phosphatases, based on their substrate specificity and pharmacological properties: Type 
1 (PP1) and Type 2 (PP2). There are two main differences and the first one is the 
subunit of phosphorylase kinase that is acted on as substrate. PP1 acts on the beta 
subunit while PP2 dephosphorylates the alpha subunit. The second difference is the 
effect of nanomolar concentrations of two small peptide inhibitors; inhibitors 1 and 2 
inhibit PP1 while PP2 is insensitive to them. PP2 enzymes are further divided according 
to their dependence on external divalent cations: PP2A, like PP1, does not require them 
for activity while PP2B and PP2C are activated by Ca2+ and Mg2+, respectively. 
Okadaic acid and calyculin A are considered as potent inhibitors of PP1 and PP2A but 
are not effective with PP2B and PP2C. PP1 and PP2A sequences are highly conserved 
among eukaryotes and are about 50% identical (Cohen, 1989; Luan, 2003). The crystal 
structure shows that some intrinsic metal ions are important for the catalytic reaction 
such as Mn2+ for PP1 (Egloff et al., 1995). 
  More than 90% of protein Ser/Thr phosphatase activity in eukaryotic cells is 
contributed by PP2A and PP1 enzymes, so they are considered as main regulators of a 
variety of important cellular processes in yeast and other eukaryotes (Ceulemans and 
Bollen, 2004; Castermans et al., 2012). PP1s can be considered as a “green” enzyme 
because it promotes the rational use of energy, a reversal of the cell to a basal and/or 
energy-conserving state and the recycling of protein factors. When nutrients are 
abundant PP1s promote the storage of energy in the form of glycogen. PP1s also play a 
role in the recycling of transcription and splicing factors and the return to basal patterns 
of protein synthesis; moreover, it has a main role in the recovery from stress but 
promotes apoptosis when cells cannot be repaired. In addition, PP1 downregulates ion 
pumps and transporters in different tissues and finally, stimulate exit from mitosis, 
modulate actin organization and keep cells in the G1or G2 phases of the cell cycle. 
Finally, in yeast PP1s modulate sporulation and glucose repression (Santangelo, 2006; 
Stark, 1996 and 2004).  
In this respect there are two yeast protein phosphatases that may participate in the 
regulation of Pma1: the major PP1 Glc7 has been connected with ion homeostasis 
(Williams-Hart et al., 2002), and the PP2A Sit4 controls yeast growth in a similar way 
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that Pma1, promoting progression through the START or restriction point of the G1 
phase of the cell division cycle (Cid et al., 1987; Sutton et al., 1991; Johnson and 
Skotheim, 2013; Dechant et al., 2014).  
 
Figure 17. Subunit composition and regulation of PPP family enzymes. PP1 holoenzymes are 
heterodimers composed of catalytic PP1c and regulatory R subunit. PP2A holoenzymes exist in either 
heterodimer or heterotrimer form the C-subunit (PP2Ac), and a scaffolding protein, the A subunit. The 
substrate specificity of PP2A as well as its intracellular localization are defined by an array of distinct 
groups of B-type regulatory subunits that bind to the AC dimeric core to form a variety of heterotrimeric 
complexes (Mumby and Walter, 1993). PP2B is often present in a heterodimer form with low activity 
(catalytic CnA and regulatory CnB) under “resting” levels of calcium. Elevated levels of calcium recruit 
calmodulin (CaM) into the heterodimer to form highly active trimeric enzymes (Luan, 2003). 
 
 
Glc7 protein phosphatase 
In yeast, Glc7 is a Ser/Thr PP1 that was first discovered upon examination of 
glycogen synthase activity in a collection of glycogen-deficient mutants, glc1-glc8, 
where the glc7 mutant strain had the greatest effect. Upon cloning and sequencing it 
was found that GLC7 encodes a major PP1 enzyme and the decreased protein 
phosphatase activity in the glc7 strain was partly restored by transformation with a 
plasmid carrying the GLC7 gene (Feng et al., 1991). Glycogen synthase is activated by 
dephosphorylation (Rothman-Denes and Cabib, 1971) and decreased Glc7 activity 
impairs the activation of glycogen synthase. The GLC7 gene has 1,464 bp with a 525-bp 
intron after codon 59. There is a single copy of GLC7 in S. cerevisiae, its mRNA length 
is 1.4-kilobase and it increases 4-fold at the end of exponential growth, suggesting that 
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that is assembled by the heterodimer core and one of the regulatory B subunits
(134) (Figure 2). Genes for both catalytic and regulatory A and B subunits have
been identified from plants. Following the initial cloning of a PP2A catalytic
subunit from B. napus (84), similar genes have been found in other plants such
as alfalfa (103) and Arabidopsis (5, 16). High sequence similarity (over 80%) has
been found between plant enzymes and animal homologues. Genes for the 65-kDa
A regulatory subunit and for B subunits have also been cloned from Arabidopsis
(43, 71, 107, 113, 135). The deduced peptide sequences of plant A andB regulatory
subunits share approximately 70% similarity with animal homologues.
Despite strong evidence for the function of PP2B-like activity (2, 14, 80, 99),
no plant gene has been identified for a typical catalytic subunit that resembles an-
imal PP2B. A multigene family encoding calcineurin B–like (CBL) proteins has
been identified (70), but further studies identified a family of novel protein kinases
(referred to as CIPKs) as targets for CBLs (79, 111). A surprising finding of a
Figure 2 Subunit composition and regulation of PPP family enzymes. PP1 holoenzymes
are heterodimers composed of catalytic PP1c and regulatory R subunit. PP2A holoenzymes
exist in either heterodimer or heterotrimer form. PP2B is often present in a heterodimer
form with low activity (catalytic CnA and regulatory CnB) under “resting” levels of calcium.
Elevated levels of calci m recruit calmodulin (CaM) into the heter dimer to form highly
active tri eric e zymes.
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activation of glycogen synthase is mediated by increased expression of PP1 as cells 
reach stationary phase (Feng et al., 1991). GLC7 deletion is lethal yet the essential 
function is not the regulation of glycogen synthase because disruptions in both known 
genes encoding this enzyme still produce a viable mutant. More experiments are 
required to identify targets of the Glc7 phosphatase in S. cerevisiae . 
           Glc7 has an important role in regulating the expression of amino acid 
biosynthetic genes in yeast cells, through dephosphorylation of eIF-2α (see Figure 15). 
In S. cerevisiae, amino acid starvation, or a defective aminoacyl-tRNA synthetase, leads 
to increased transcription of more than 30 genes encoding amino acid biosynthetic 
enzymes, in a mechanism known as “general amino acid control” or “general control of 
nitrogen metabolism” (GCN). The immediate effector of the general control response is 
the Gcn4 protein, a transcriptional activator that binds upstream of all the amino acids 
biosynthetic genes that are subject to the general control. Expression of Gcn4 itself is 
regulated by amino acid availability; on amino acid starvation Gcn2 stimulates Gcn4 
expression by phosphorylating eIF-2α and increasing translation of its mRNA 
(Hinnebusch, 2005). 
Some important regulatory subunits of Glc7 and their functions (between 
brackets) are: Gip1 (sporulation), Reg1 (glucose repression), Gac1 and Pig1 (glycogen 
metabolism), Scd5 (actin organization) and Reg2 and Sds22 (cell cycle progression) 
(Santangelo, 2006). The glycogen accumulation defect of glc7-1 is due at least in part to 
the inability of the mutant protein phosphatase to interact with its regulatory subunit 
Gac1 (Stuart et al., 1994). A short motif present in most known regulatory subunits is 
very important in the interaction with a hydrophobic groove in PP1 (Egloff et al., 1997). 
The multiple regulatory subunits compete for Glc7 binding in vivo and almost all of 
them interact with more than one site on the PP1 surface (Wu and Tatchell, 2001).  The 
Glc7 localization pattern dynamically changes throughout the yeast cell cycle due to the 
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Sit4 protein phosphatase 
 Yeast has two PP2A catalytic subunits, Pph21and Pph22 and three PP2A-like 
catalytic subunits: Sit4, Pph3 and Ppg1. PP2As are involved in a lot of cellular 
processes, including signal transduction, metabolism, cell cycle progression, gene 
expression, and protein translation (Stark, 1996 and 2004; Castermans et al., 2012). Sit4 
promotes progression through G1, via regulation of G1 cyclin production (Sutton et al., 
1991). The regulatory subunits of Sit4 include several members of the SAP family 
(Luke et al., 1996) and a novel regulatory subunit termed Tap42 in yeast (Di Como and 
Arndt, 1996). This regulatory subunit interacts with Sit4 when TORC1 is active and it 
disassociates from the phosphatase when TORC1 is inhibited (Di Como and Arndt, 
1996) (see Figure 13). The interaction of Sit4 with Tap42 is required for the function of 
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                                                     OBJECTIVES       
  
Taking in consideration the background information presented at the 
introduction, the objectives of the present thesis are as follows: 
 
1- Determine if Glc7, the major PP1 protein phosphatase of yeast and also implicated 
 in ion homeostasis, has a role in the activation of yeast plasma membrane H+-
 ATPase (Pma1) by glucose 
 
2- Determine if Sit4, a PP2A protein phosphatase implicated in yeast growth, has a 
 role in the activation of Pma1 by glucose 
 
3- Investigate the participation of the growth-promoting protein kinase TORC1 in the 
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                                 MATERIALS AND METHODS     
1. Materials 
1.1. Strains and culture conditions of bacteria 
  Strain DH5α of Escherichia coli, E. coli, was used for the isolation and propagation 
of plasmids. Standard methods were used for bacterial culture and manipulation 
(Sambrook and Russell, 2001). Cells were grown at 37°C in LB (Luria Bertani) medium 
(0.5% yeast extract, 1% tryptone, 1% NaCl adjusted to pH 7 with NaOH). If solid medium 
was required 1.5 % agar was added. For plasmid selection, 50 µg/ml ampicillin was added 
and if applicable: X-Gal (isopropyl β-D-1-thiogalactopyranoside) and IPTG (isopropyl β-
D-1-thiogalactopyranoside) were also added to a final concentration of 10 µg/ml. 
 
1.2. Strains and culture conditions of yeast 





RS-58 BWG1-7A (MATa ade1-100 ura3-52 leu2-3112 
his4-519) 
Guarente et al., 
1982 
 RS-58 /YEp24 G. Hueso 
 RS-58 /YEp24-GLC7’ G. Hueso 
 RS-58 /YEp352 This study 
 RS-58 /YEp352-GLC7’ This study 
RS-132 RS-58 transformed with LEU2 fragment  R. Serrano 
 RS-132 / pUN50 This study 
 RS-132 / pUN50-GLC7’ This study 
 RS-132 / YEp352 This study 
 RS-132 / YEp352-GLC7’ This study 
RS-259 BY4741 (MATa ura3-∆0 leu2-∆0 his3-∆1 meth15-
∆0) (derived from S288C) 
Euroscarf 
RS-119 RS-259 / PCM262  G. Hueso 
RS-120 RS-259 / PCM262-GLC7'-HA3-His6 G. Hueso 
RS-121 RS-259 / PCM262-GLC7' G. Hueso 
	  




 RS-259 / pYEX 4T-1 This study 
 RS-259 / pYEX 4T-1-SIT4 This study 
RS-1373 KT1112 (MATa ura3-52 leu2 his3)  Stuart et al., 1994 
RS-1376 RS-1373 glc7-109 Williams-Hart et 
al., 2002 
RS-1377 RS-1373 glc7-132 Williams-Hart et 
al., 2002 
RS-1379 RS-1373 glc7-1 Stuart et al., 1994 
RS-624 BY4741 GCN2c Menacho-Marquez 
et al., 2007 
  BY4741 Sit4Δ Euroscarf 
SH221 MATa leu2-3,112 trp1 ura3 rme1 his4 HMLa 
ade2 his3 HIS4 tor1::HIS3 tor2::ADE2 / 
YCplac111::tor2-21ts 
Helliwell et al., 
1998 
SH100 MATa leu2-3,112 trp1 ura3 rme1 his4 HMLa    
ade2 tor2::ADE2 / YCplac111::TOR2 
Helliwell et al., 
1998 
   
Yeast cells were cultured and manipulated following standard methods (Sherman, 1991). 
Temperature was 28°C unless otherwise mentioned, with shaking (180 - 200 rev/min) in 
the media described below: 
Minimal medium (SD) 
Synthetic Dextrose: 2% glucose, 0.7% Yeast Nitrogen Base (YNB) without amino acids, 
50 mM MES-Tris pH 5.5. Whenever required, amino acids (0.10 mg/ml methionine, 0.10 
mg/ml leucine, 0.03 mg/ml histidine) and nitrogen bases (0.03 mg/ml adenine, 0.03 mg/ml 
uracil) were added. 
Minimal complete medium (SCD) 
Synthetic Complete Dextrose: 2% glucose, 0.7% YNB, 50 mM MES-Tris pH 6. This 
medium contains all amino acids and nitrogen bases except when there is a need for 
plasmid selection, then some of them such as uracil or leucine were removed.  
YPD 
Rich (complete) medium: 1% Yeast extract, 2% Bacto Peptone, 2% glucose. Agar 2% is 
added whenever solid media was required.  
	  





 All plasmids used in this study are listed in Table 2: 
Plasmid Description Reference 
YEp24 Ampr, 2µ, URA3 Botstein et al., 1979 
YEp352 Ampr , 2µ, URA3 Hill et al., 1986 
pUN50 Ampr , CEN, URA3 Elledge and Davis, 
1988 
pCM262 Ampr , 2µ, URA3 Ariño and Herrero, 
2003 
pYEX 4T-1 Ampr Amrad Biotech 
(Ward et al., 1994) 
pGEX-3X Ampr Smith and Johnson, 
1988 
pCM262-GLC7’-HA3-His6  G. Hueso (see 
methods) 
pCM262-GLC7’  G. Hueso (see 
methods) 
pGEX-3X-GLC7  Rodriguez-Hernandez 
et al., 2012 
YEp24-GLC7’  Hueso et al., 2012 
YEp352-GLC7’  This study 
pUN50- GLC7’  This study 
pYEX 4T-1-SIT4  This study 
 












Figure 18. Restriction map of YEp24, an episomal (2µ origin, high-copy number) vector with 
a URA3 marker for selection in yeast. Confers ampicillin resistance for selection in E. coli. 
(Botstein et al., 1979). http://www.snapgene.com/resources/plasmid_files/yeast_plasmids/YEp24/ 
 
	  






Figure 19. Restriction map of YEp352. An episomal (2µ origin, high-copy number) cloning vector 
with a URA3 marker for selection in yeast. Contains the β-lactamase gene that confers ampicillin 
resistance for selection in E. coli (Hill et al. 1986). 
 
Figure 20. Restriction map of pCM262, an episomal (2µ origin, high-copy number) plasmid used 
for expression and isolation of recombinant proteins in yeast. It contains a cloning site that allows 
cloning a gene in reading frame with six histidine and three copies of epitope HA under control of a 
doxycycline regulated promoter (Ariño and Herrero, 2003). 





EcoRl nl BamHI SalI Sphl 
(MCS) = I : h i :  I I :  I 
Sac1 Smol Xbal Pstl Hindlll 
Figure 1. Restriction maps of YEp351 and YEp352. Only unique restriction sites are shown. (MCS) 
represents the multiple cloning region of pUCI8 (Yanisch-Perron et al., 1985) including EcoRZ (E), 
SstI, Kpnl, SmaI, BamHI, XbaI, SalI, PstI, SphI, and HindIII (H). Nucleotide number 1 in each vector 
is the 'A' of the initiation codon of lacz'. The solid areas represent yeast genomic sequences, the open 
areas represent PUCl8 sequences, and the cross-hatched areas represent yeast 2 p circle sequences. In 
YEp351 the yeast genomic sequence includes nucleotides 286-2256, the 2 ~1 circle sequence includes 
necleotides 2257-3241, and the pUC18 sequence includes nucleotides 3442-285. In YEp352 the yeast 
genomic sequence includes nucleotides 286-1383, the 2 p circle sequence includes nucleotides 
138&2768, and the pUC18 sequence includes nucleotides 2769-285. The sequences marked A have been 
deleted from YEp351 and YEp352 to construct YIp351 and YIp352, respectively. The sequence deleted 
from YEp35 1 includes nucleotides 2259-3492 and the sequence deleted from YEp352 includes nucleo- 
tides 161 1-2489. 
The latter fragment was isolated from the 1.2 kb 
HindIII fragment containing URA3 (Rose et al., 
1984) cloned into pUC18. Both the pUC18 and the 
URA3 fragments were made blunt-ended with 
Klenow polymerase prior to the ligation. Follow- 
ing transformation of E. coli, clones were selected 
for ampicillin resistance and uracil independence. 
Surviving clones which also contained the 2 p circle 
sequence were identified by colony hybr disation 
using the 1.4 kb Rrsalfragment of this episome a  a
probe. Several clones were confirmed by restriction 
mapping to have plasmids containing all three 
fragments used in the ligation. 
One such plasmid was further modified by 
removal of the second XbaI and PstI sites present 
in the 2 p circle and in the URA3 segments of the 
vector, respectively. The plasmid was first partially 
digested with XbaI and the linear plasmid consist- 
ing of a mixture cut either in the muliple cloning 
region of pUC18 or in the 2 p  circle region was 
isolated. The linear plasmid was treated with 
Klenow fragment and religated. After transforma- 
tion of E. coli RR1, ampicillin-resistant clones were 
screened for plasmids containing the Xbal site in 
the pUC 18 multiple cloning region but lacking the 
site in the 2 p circle region. This plasmid was used 
to eliminate the PstI site in the 5' non-coding region 
of the URA3 gene by an analogous procedure. In 
his case the 3' protruding e ds of the PstI ites 
were removed by digestion with S1 nuclea e. The 
resultant vector YEp352 is unique for all six base 
pair recognition sites of the pUC18 multiple 
cloning region (Figure 1). 
To derive the complete nucleotide sequences of 
YEp351 and YEp352 all the regions at the ligated 
junctions and at the destroyed PstI and XbaI sites 
were sequenced. In every case the sequences were 
consistent with what was expected based on the 
known sequences of the DNA fragments used 
for the constructions. The complete nucleotide 
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pair recognition sites of the pUC18 multiple 
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To derive the complete nucleotide sequences of 
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known sequences of the DNA fragments used 
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Figure 21. pGEX-3X is a GST-fusion vector for expression in E. coli under control of tac promoter 






Figure 22. pYEX 4T-1 is a GST-fusion vector for protein expression in yeast under control of the 
Cu2+-inducible CUP1 promoter. The GST coding region encodes a protein of approximately 27.5 
kDa. It includes the E. coli Ampr gene and the yeast selectable marker URA3. It is maintained at 
high copy number by leu2-d (a LEU2 gene with a truncated, inefficient promoter) during growth 








2. Isolation of yeast membranes and “in vitro” determination of Pma1 activity  
(Modified from Serrano, 1983 and 1988) 
2.1. Isolation of yeast membranes 
2.1.1. Culture preparation 
         A single yeast colony was inoculated in 2 ml medium and grown to stationary phase 
at 30°C with shaking at 200 rev/min. This culture was stored in the cold and used as 
inoculum. A flask of 250 ml with 50 ml medium was inoculated with the saturated culture 
(50-500 µl) and incubated at 30°C with shaking at 200 rev/min to reach exponential phase 
or stationary phase as specified in each experiment.  
 
2.1.2. Membrane isolation  
         The 50 ml culture (50-100 mg FW cells) was centrifuged during 5 min at 3,000 
rev/min in a Nahita 2655 centrifuge and resuspended in 25 ml sterile water, centrifuged 
again and finally resuspended in 2 ml sterile water. The concentrated and washed cells 
were incubated for 15 min at 30°C and 1 ml was taken and frozen in liquid nitrogen 
(Glucose Starved or GS sample). Then 2% final glucose was added to the other 1 ml which 
was then incubated for 10 min at 30°C and frozen in liquid nitrogen (Glucose Fermenting 
or GF sample). For cell homogenization, 200 µL of protein extraction buffer 5x (0.25 M 
Tris- HCl pH 8, 0.3 M KCl, 25 mM EDTA, 10 mM DTT and protease inhibitor cocktail 
from Roche) was added to 1 ml cell suspension, 1.5-2 ml of glass beads (0.5 mm diameter) 
were added and vortexed for six cycles of 30 sec vortex and 30 sec incubation in ice. Cell 
debris was removed by centrifugation of the homogenate 2 min at 3,000 rev/min at 4°C in 
an Eppendorf R5426 centrifuge and a membrane fraction was obtained from the 
supernatant by centrifugation 20 min at 13,000 rev/min and 4 °C in the same refrigerated 
centrifuge as before. The pellet was resuspended with a Dounce-type manual homogenizer 
in 100 µL of cold GTED 20 solution (20% glycerol, 10 mM Tris HCl pH 7.6, 1 mM EDTA 
and 1 mM DTT) and diluted with 900 µL cold distilled water to lyse the membranes and 
wash free of inorganic phosphate. After a final centrifugation of 30 min at 13,000 rev/min 
at 4°C membranes were resuspended in 150 µL cold GTED 20, divided into several micro 









2.2. Protein determination by the method of Bradford (1976) 
   In a microtiter plate, duplicates of 0, 2, 4, 6, 8,10 µL of the standard bovine-ɤ-
globulin 1 µg/µL were placed in the wells. Triplicates of the membrane preparations  (2-10 
µL) were also placed. Then 150 µL of the freshly diluted 5X BioRad Protein assay reagent 
(BioRad) was added to each well, gently mixed and left 25 minutes for the blue color to 
stabilize. Finally, the absorbance was measured at 595 nm using an iMark™ Microplate 
Absorbance Reader (BioRad). Protein concentration in the membrane preparations was 
calculated from the calibration curve. 
 
2.3. Determination of Pma1 activity  
 Triplicates of 3-10 µg protein in less than 5 µL of yeast membranes were placed in two 
rows of wells of microtiter plates. The reaction was started in one row by adding preheated 
(10 min, 30°C) 65 µL of ATPase reaction buffer (50 mM MES-Tris pH 5.7, 5 mM MgSO4, 
50 mM KNO3, 5 mM sodium azide, 0.3 mM ammonium molybdate, 2 mM ATP, the latter 
added at the moment of use). To the other row, the same preheated buffer but containing 
0.15 mM sodium orthovanadate (Na3VO4) was added. The plate was incubated (30 min, 
30°C). The reaction with terminated by adding 130 µL of phosphate reagent (2% H2SO4, 
0.5% ammonium molybdate, 0.5% SDS, 1% ascorbic acid, the latter added at the moment 
of use). As standard, duplicates were prepared with 0, 2, 4, 6, 8, 10 and 20 µL of 5 mM 
inorganic phosphate (Pi) to which ATPase reaction buffer was added followed by 
phosphate reagent in the same manner as the tested samples. The microplate was left for 25 
minutes for the blue color to stabilize and then the absorbance was measured at 750 nm 
using an iMark™ Microplate Absorbance Reader (BioRad). Pi concentration was 
calculated from the calibration curve with standard Pi. Pma1 activity was defined as the 
vanadate-sensitive component of the total ATPase activity and it corresponded to 80-90 % 
of the latter. 
 
3. Assay for Pma1 activity in membrane preparations of cells treated with PP1 
inhibitors 
3.1. Treatment of yeast cells with the phosphatase inhibitor 
        S. cerevisiae strain RS-58 was used for this experiment and it was grown in YPD 
medium to stationary phase. Cells were washed, concentrated and preincubated in H2O as 
	  




described above and then protein phosphatase 1 inhibitors were added as described below. 
The stock solutions were: okadaic acid (MW= 805) 0.1 mM in methanol, calyculin A 
(MW= 805) 0.2 mM in methanol and tungstate (MW= 330) 1 M in water. Harvested and 
washed cells were divided into 4 portions, 1ml each. Two portions did not receive any 
inhibitor, and glucose was only added to one of them and processed as described above. To 
the other two portions, one inhibitor was added (final concentration 0.5 µM okadaic acid, 1 
µM calyculin A and 10 mM tungstate) together with glucose to one portion and without 
glucose to the other one. Then all samples were incubated for 20 min at 30°C and Pma1 
activity determined as described above. Okadaic acid was obtained from Kamiya 
Biomedical Company (Seattle, USA), calyculin A from LC Laboratories (Woburn, MA, 
USA) and tungstate from Fisher Scientific (Madrid, Spain). 
3.2. Growth inhibition test  
To detect the effect on yeast growth of every phosphatase inhibitor, an stationary 
phase culture of RS-58 was used to inoculate 2 ml of YPD (initial OD of about 0.1) and 
okadaic acid (0, 0.1 and 0.5 µM, calyculin A (0, 2 µM) or methanol (as a control) were 
added. All tubes were incubated (24 hrs, 200 rev/min, 30°C) and OD was measured at 660 
nm.  
4. Assay for yeast tolerance to toxic cations 
         Serial dilutions of stationary phase cultures of the specified strain were spotted (about 
3 µL) with either a replicator (Sigma) or by micropipetting on a plate of solid medium with 
the indicated toxic cations (see Goossens et al., 2000). Plates were incubated for 2-3 days 
at 28°C.  
 
5. Purification and manipulation of nucleic acid 
5.1. Isolation of plasmid DNA from E. coli 
 A modified small-scale alkaline lysis method (Birnboim, 1983) was employed. 1.5 
ml of overnight culture in LB with amplicillin was pelleted by centrifugation for 1 min at 
13,000 rev/min in an  Eppendorf D5425 centrifuge. Pellet was resuspended  in 200 µL of 
GTE buffer (50 mM glucose, 25 mM Tris, pH 8, 10 mM EDTA, pH 8). 300 µL of freshly 
prepared solution with 0.2 N NaOH and 1% SDS  was added,  mixed by tube inversion and 
left on ice for 5 min. Then 300 µL of 3.0 M potassium acetate taken to pH 4.8 with acetic 
acid was added, mixed by inversion and left on ice for 5 min. The tube was centrifuged for 
	  




10 min as before and the supernatant transferred  to a new tube. RNAse A was added to 20 
µg/ml and incubated 20 min at 37°C.  A chloroform extraction was made using 2 volumes 
of organic solvent,  mixed by shaking then spinned for 1 min in top speed  and the aqueous 
phase saved to a new tube. DNA was precipitated  by adding an equal volume of 
isopropanol, incubation in ice for 1 hour or more and centrifuged 10 min at top speed. The 
pellet was washed with 500 µL of 70% etanol, which was then poured after centrifugation 
for 1 min. Finally the pellet was dried in a vacuum centrifuge and resuspend in 25 µL TE 
buffer. 
 
5.2. Isolation of yeast genomic DNA  
          A modified small-scale protoplast method (Winston et al., 1983) was employed. 
Yeast was inoculated in 5 ml YPD and incubated till reaching late exponential phase (OD 
at 660 nm= 1-2 measured in a DINKO SP8001 spectrophotometer, Barcelona, Spain). 
Cells were harvested by centrifugation 5 min at 3,000 rev/min (Eppendorf D5425 
centrifuge), resuspended in 1 ml SoE solution (0.9 M sorbitol, 0.1 M EDTA, pH 8 with 
NaOH), centrifuged again and resuspended in 200 µL SoE to which 10 µL of DTT 0.5 M 
and 25 µL 1% zymolyase 100T (Miles) were added, mixed and incubated 30 min at 37°C 
to make protoplasts. Then 500 µL of TCES (0.2 M Tris, 0.2 M NaCl, 50 mM EDTA, 2% 
SDS adjusted to pH 8 with HCl), 2 µL β-mercaptoethanol and 4 µL of 2% protease K were 
added and incubated 30 min at 65°C. Protoplasts were extracted with 0.7 ml PCI (phenol: 
chloroform: isoamyl alcohol, 25: 24: 1) followed by centrifugation 5 min at 11000 rev/min. 
DNA was precipitated from the aqueous phase by adding an equal volume of isopropanol 
and incubation in ice for 15 min or more. The pellet was washed with 500 µL 70% etanol 
which was then poured after centrifugation. The pellet was resuspended in 400 µL H2O 
with 5 µL RNAase 1% and incubated 30 min at 37°C. Then  extraction was made with an 
equal volume of  PCI and centrifugation to take the aqueous phase. DNA was precipitated  
by adding 1 ml etanol:ammonium acetate 6:1 (6 volumes of absolute etanol+ 1 volume 
ammonium acetate 7.5 M) and incubation in ice for 15 min or more. After centrifugation 
during 15 min at 13,000 rev/min, the pellet was washed with  1 ml 70% ethanol which was 
then poured after centrifugation. The pellet was dried by leaving the tube open in RT for 
20 min and resuspended in 30 µL TE by shaking for about 30 min. 
 
	  




5.3. DNA electrophoresis 
         To detect the integrity of isolated genomic DNA and the result of PCR or restriction 
endonuclease reactions, we made an electrophoresis of DNA. An agarose gel at 0.7% was 
prepared in electrophoresis buffer TBE 0.5X (45 mM Tris-base, 45 mM boric acid, 1 mM 
EDTA pH 8). The electrophoresis buffer and also the gel buffer contained 0.5 µg/ml 
ethidium bromide. Before injecting the samples into the wells they were mixed with 
loading buffer 6X (0.25% bromophenol blue, 40 % sucrose, 0.1 M EDTA). Markers used 
were 1KB or λ DNA digested with Hind III (Invitrogen). Bands were detected  under  UV 
light of 254 nm wavelength.  
 To purify DNA fragment from preparative gels a  “NucleoSpin DNA purification” 
kit (Macherey-Nagel) was used. 
 
5.4. Preparation of RNA from S. cerevisiae 
Steps were basically according to (Li et al., 2009). 
 
5.4.1. Culture preparation  
         To detect the expression of GLC7’ in strain RS-121 after doxycycline removal, an 
exponential phase culture of 15 ml was prepared in medium with doxycycline as described 
above. Cells were harvested by centrifugation (1 min at 13,000 rev/min), washed with 
water twice and resuspended in the same volume of medium. Then divided into 4 portions 
of 5 ml and 2 µg/ml doxycycline final concentration was added to two of them. Two tubes 
with doxycycline and two tubes without were incubated for 1.5-2 h before RNA isolation.  
 
5.4.2.  RNA Isolation 
         Cells were harvested by centrifugation (1 min at 13,000 rev/min), resuspended in 100 
µL RNA extraction buffer (50 mM tris pH 6, 10 mM EDTA, 5% SDS) and incubated (5 
min, 65°C). Then 50 µL of K buffer (KCl 0.3 M + 10 mM MES –Tris pH 6) were added to 
precipitate denatured proteins and SDS, mixed thoroughly and the tube incubated 5 min in 
ice. After centrifugation (5 min, 13,000 rev/min) the supernatant was transferred to new 
microtubes and an equal volume of acidic phenol was added and well mixed for phase 
partition. To remove any remaining proteins, another centrifugation (5 min, 13,000 
rev/min) was made and the upper phase was taken, to which 0.1 volume of NaAc 3M pH 
5.2 and 2.5 volumes absolute ethanol were added followed by incubation (15 min at -
20°C). RNA was precipitated by centrifugation (10 min, 13,000 rev/min), the pellet was 
	  




washed with 70 % ethanol which was then removed after centrifugation. The microtube 
was left open in the air to dry the pellet which was finally resuspended in 20 µL RNAase-
free water and stored at -80°C till further processing. 
 
5.5. RNA gel electrophoresis 
 
        To test the integrity of the RNA preparation samples were applied to a 1% agarose gel 
prepared in TAE buffer (40 mM Tris-acetic acid pH 8.0 and 1 mM EDTA). The samples 
and the ladder standard (0.5-10 kb RNA ladder) were prepared with loading buffer 1.25X 
[12.5% MAE 10X (0.2 M MOPS, 50 mM Na Acetate, 10 mM EDTA, pH 7), 55% 
formamide, 20% formaldehyde, 8% glycerol, 0.05% bromophenol blue, 0.001% ethidium 
bromide] and incubated (10 min, 56°C) before loading into the wells. The electrophoresis 
was run in TAE buffer.  
 
5.6. Synthesis of cDNA   
                  The extracted RNA was purified with a NucleoSpin RNA kit and checked again 
for integrity.  This purification also eliminated contaminating DNA in the RNA samples by 
a treatment with DNAase when the RNA is bound to the silica gel plate 
         The RNA eluted from the silica gel plate (20 µL) was mixed with 6 µL of 5X 
Reaction Mix and 2 µL of Maxima Enzyme Mix (Thermo Scientific) in a final reaction 
volume of 30 µL and incubated in two steps, first for 10 min at 25°C then for 30 min at 
50°C. Finally the reaction was inactivated by heating at 85°C for 5 minutes. 
 
5.7. PCR  
For PCR or semi-quantitative RT-PCR, the following PCR reaction mixture was made: 
! 0.5 µL cDNA (see above) or 10 ng DNA template 
! 2 µL PCR buffer 10X (with 1.5 mM MgCl2) 
! 2 µL dNTPs 10 mM 
! 0.5 µL Forward primer 20 µM 
! 0.5 µL Reverse primer 20 µM 
! 0.5 µL polymerase (Taq) 1U/ µL 
! Complete to 20 µL with sterile miliQ H2O 
 
For reactions that required DNA amplification of high fidelity, the enzyme 
Phusion High-Fidelity DNA polymerase (New England Biolabs) was applied with 
all the conditions and PCR program mentioned in the company booklet. 
 
	  




All the PCR reactions were made in Mastercycler personal (Eppendorf), those with Taq 
received the following PCR program: 
• 1 cycle of initial denaturation at 95°C for 5 min 
• 25 cycles, for semi-quantitative RT-PCR, or 30-35cycles, for normal PCR, of:  
! Denaturation at 95°C for 30 sec 
! Hybridization for 30 sec at an annealing temperature 2 degrees 
lower than the Tm of the primers 
! Extension at 72°C for 1 min for 1 KB. 
• 1 cycle of final extension at 72°C for 3-5 min 
• Hold at 4°C  
 
Table 3:  Primers used for PCR reactions. See Figure 23 for explanation. 
 
Name                Sequence (restriction sites underlined) Product size 
(kb) 
GLC7’c F      CCGGAATTCATTTCTTGTGAGCACAACCTC 
GLC7’c R      CGCGGATCCTTATGGATCTGACCACAATAAGTCA 
 
1.6 
GLC7´d, e F   TATGCGGCCGCTATGGACTCACAACCAGTT 
GLC7’d R      ATAAGCGGCCGCCTAGATCTGTTCCATACTATT 
1.1 
 
GLC7’d, e F    see above 
GLC7’e R      ATAAGCGGCCGCGATCTGTTCCATACTATT 
1.1 
GLC7’f  F      GAGGGAACCATGAATGTGCTTC 
GLC7’f R       CTGGTGATCCGTCGACCTGCA 
0.23 
UBC6 F         CGGCAAATACAGGTGATGAAAC  
UBC6 R        TTCAGCGCGTATTCTGTCTTC  
0.11 
SIT4 F           GCGGAATTCATGGTATCTAGAGGCCCCG 
SIT4 R           GCGCTCGAGGTTATAAGAAATAGCCGGCTC 
1 
 
           For semi-quantitative RT-PCR, a cDNA from wild type yeast, non-transformed with 
a GLC7’ plasmid, was used to check the primer specificity. Other than GLC7’ primers, 
UBC6 primers were applied on the samples cDNA for another PCR reaction mixture as a 
control. UBC6 is a house-keeping gene with constant levels of expression. RT-PCR 
product samples were checked by DNA electrophoresis using 2% agarose gel. The length 
of the amplified sequence is 227 bp for GLC7’ and 107 bp for UBC6. 
 
5.8. Plasmid construction 
          GLC7’c (truncated GLC7 under control of its own promoter) of 1.6 kb was produced 
by PCR using yeast genomic DNA as a template and primers GLC7’c F and GLC7’c R, 
containing sites for EcoRI and BamHI, respectively (Table 3). The fragment of 1.6 kb was 
	  




inserted into centromeric plasmid pUN50. An episomal version was produced by blunt end 
ligation with plasmid YEp352 after cutting with SmaI.  
 Starting from the 1.9 kb GLC7’ fragment isolated by Hueso et al. (2012), two 1.1 
kb fragments containing the ORF of the truncated gene (GLC7’d and GLC7’e) were 
amplified with Phusion High-Fidelity DNA polymerase (New England BioLabs) and 
primers GLC7’d, e F and GLC7’d R (for GLC7’d gene) and primers GLC7’d, e F and 
GLC7’e R (for GLC7’e gene). All primers contained NotI restriction sites and in the first 
case the GLC7’d ORF contained a stop codon but in the second (GLC7’e) there was no 
stop codon. The amplified fragments were digested with NotI and cloned into the NotI site 
of plasmid pCM262, resulting in doxycycline-regulated expression of the simple truncated 
protein (GLC7’d) or expression of a C-terminal in-frame fusion with 3 repetitions of the 
HA antigen and 6 histidine codons (GLC7’e) (Ariño and Herrero, 2003).  
          SIT4 was produced by PCR using yeast genomic DNA as a template and primers 
SIT4F and SIT4R, containing sites for EcoRI and XhoI, respectively (Table 3). The 
fragment (≈1 kb) was inserted into plasmid pYEX 4T-1 to be expressed in yeast. 
There were many previous trials to express Sit4 in E. coli in the soluble fraction but 
in all of them the protein always was produced in the inclusion bodies. The SIT4 fragment 
was inserted into plasmid pGEX-KG. Because of the slight difference in the reading frame 
of the two plasmids (pGEX-KG and pYEX 4T-1) the forward primer was different: SIT4 F 
GCGGAATTCTAATGGTATCTAGAGGCCCCG while the reverse primer was the same. 
Then several trials were made, using different IPTG concentrations and induction 
temperature and times (37°C, 0.4 mM IPTG for 17, 30, 40, 50, 60, 90 minutes and 20°C, 
0.4 mM IPTG with sorbitol 0, 500 and 333 mM for 17, 30, 45 minutes and 1, 2, 3, 4, 5 
hours). We tried also to transform the plasmid to another strain (BL21) by electroporation; 
again the expressed Sit4 was in the inclusion bodies. The second construct was by cutting 
SIT4 from pGEX-KG and putting it directly on pMAL plasmid, then trying to express Sit4 
under different conditions (37°C, 0.4 mM IPTG for 0.5, 1, 2 hours; 22°C, 0.4 mM IPTG 
for 0.5, 1, 2 hours) induction occurred at both temperature tested but never in soluble 













































Figure 23. Nucleotide sequence of chromosome V from coordinates 431670 to 433643, including 
the truncated GLC7’ genes of Wek et al. (1992; gene GLC7’a of 1.6 kb), Hueso et al. (2012; gene 
GLC7’b of 1.9 kb) and the one generated in the present work (GLC7’c). Small letters correspond to 
the intron of the gene. GLC7’a extends from the Hind III site underlined (AAGCTT) to the end of 
the sequence (codon CCA for proline 208, underlined). GLC7’b extends from the beginning of the 
sequence to the underlined codon GAA (glutamate 183). GLC7’c has 1.6 kb from the underlined 
ATT (40 nt after the Hind III site) to the end of the sequence (codon CCA for proline 208, 
underlined). GLC7’d is the coding region of GLC7’b plus two more codons, stop codon and Not I 
sites at both ends to clone into pCM262 plasmid. GLC7’e is the coding region of GLC7’b plus two 
more codons (but no stop codon) to fuse in frame with 3 repetitions of the HA antigen and six 
histidine codons. It also contains Not I sites at both ends to clone into pCM262 plasmid. GLC7’f is 
the 227 bp fragment used to quantify GLC7’d expression from the doxycycline-regulated promoter. 
It extends from the GAG … TTC primer sequence in the GLC7’ gene (underlined) to the sequence 
in the pCM262 plasmid just after the Not I cloning site (beginning of 3xHA region; Ariño and 
Herrero, 2003). The complete ORF encodes 312 amino acids. The starting codon ATG is also 
underlined. See primers at Table 3.  
	  




6. Genetic transfer 
6.1. Transformation of E. coli	  	  
        The method of Inoue et al. (1990) was used. DH5α competent cells (100 µL) were 
mixed with 10 µl ligation reaction. The mixture was incubated for  30 minutes in ice, then 
(1 min, 42˚C) and finally back to  ice for 2 minutes. 900 µL of LB medium was added and 
incubated 50 min at 37°C. Finally the cells were spread on LB agar with ampicillin for 
selection. 
6.2. Transformation of yeast  (Gietz, 2014) 
6.2.1. Preparation of competent yeast cells 
         Fresh stationary phase culture was inoculated into YPD broth and incubated till 
reaching exponential phase. Cells were harvested and resuspended in 0.1M Li Ac-TE 
(Lithium acetate 0.1 M, 10 mM Tris-HCl pH 7.6, 1 mM EDTA) with 1/10 volume of the 
culture volume. Again centifuged, resuspended in 1 ml of 0.1 M Li Ac-TE and incubated 
30 min at 30°C. Then 0.23 ml of 80% glycerol and 0.1 ml 1% single stranded salmon 
sperm DNA was added to each 1 ml volume of cells, mixed well then distributed into 100 
µL aliquots and stored at  -80°C till being used. 
 
6.2.2. Yeast Transformation 
        The competent yeast cells were mixed with 0.1-10 µg of the specific plasmid, 
incubated 5-10 min at room temperature and then 600 µL of PEG-Li Ac-TE (40% (w/v) 
PEG 4,000 in Li Ac-TE). The mixture was incubated (30 min at room temperature, then 10 
min, at 42°C), centrifuged for 10 seconds at 13,000 rev/min and cells finally resuspended 
in 200 µL water and spread on a plate with selective medium. The plate was incubated at 
28°C for 2 or more days till the appearance of colonies. 
 
7. Extraction, electrophoresis and detection of proteins 
7.1. Extraction of soluble proteins 
7.1.1. Method of boiling with Laemmli buffer 
        Cells from 5 ml of exponential phase culture were harvested, washed and put under 
the conditions of study and harvested by centrifugation during 5 min at 3,000 rev/min. The 
pellet was resuspended in 100 µL of 1X Laemmli sample buffer (5X: 7.5 % SDS, 0.1 M 
DTT, 10 mM EDTA, 30% sucrose, 0.25 mg/ml bromophenol blue, 0.3 M Tris taken to pH 
	  




6.8 with HCl), then heated 5 min at 100°C. Finally, the suspension was centrifuged during 
2 min at 13,000 rev/min and the supernatant kept at -20°C until being utilized. 
7.1.2. Method of NaOH (von der Haar, 2007) 
             Cells were harvested from 5 ml exponential phase culture as described above. 
Lysis buffer (0.1 M NaOH, 0.05 M EDTA, 2% β-mercaptoethanol and 2% SDS) was 
freshly prepared and heated at 90°C for 5 minutes before used (200 µL) to resuspend the 
cells. The resulting suspension was incubated 10 min at 90°C, then the lysate was brought 
to neutral pH by mixing well with 5 µL of 4 M acetic acid, and incubated 10 min at 90°C 
to increase solubilization. 50 µL loading buffer (0.25 M Tris-HCl, pH 6.8, 50% glycerol, 
0.05% Bromophenol blue) was well mixed and finally the suspension was centrifuged for 
(1 min, 13,000 rev/min, 4°C). Denatured proteins in the supernatant were kept at -20°C 
until being utilized. 
7.1.3. Method of TCA (Grassl et al., 2009) 
          Equal volume of 20% trichloroaceticacetic acid (TCA) was added to exponential 
phase culture, mixed well then kept in ice for 30 minutes before being centrifuged (8 min, 
3,000 rev/min). The pellet was resuspended in 1 ml cold absolute ethanol and left in ice for 
5 minutes then centrifuged (5 min, 12,000 rev/min, 4°C) and this washing step was done 
twice. The pellet was dried by leaving the microtube open for 20 minutes at RT or by 
vacuum centrifugation and was then resuspend in 1X Laemmli (200 µL) and heated 5 min 
at 100°C to solublize proteins. Finally, the suspension was centrifuged (2 min, 13,000 
rev/min, 4°C) to remove debris and the supernatant kept at -20°C until being utilized.  
7.2. Extraction of Pma1 
  The above methods cannot be utilized to extract Pma1 because it aggregates by 
boiling in Laemmli sample buffer. Instead, in the case of Pma1 the extraction of a crude 
membrane fraction must be made in the presence of protease inhibitors as described above 









7.3. Electrophoresis and detection techniques of proteins 
7.3.1. Electrophoresis of proteins 
         The denatured proteins were separated by electrophoresis in SDS-polyacrylamide 
gels  (SDS-PAGE) using Mini-Protean 3 (BioRad). The gel consisted of two layers above 
each other. The upper layer (stacking gel) consisted of (3% acrylamide: bisacrylamide 
30:0.8, 0.1 % SDS, 125 mM Tris-HCl pH 6.8) and the lower layer (resolving gel) consisted 
of (8 or 10 % acrylamide: bisacrylamide 30:0.8, 0.1 % SDS, 325 mM, Tris-HCl pH 8.8), 
 ammonium persulphate and tetraethylmethylenediamine (TEMED) were added to both 
gels. Acrylamide concentration in the resolving gel was according to the protein size, 8% 
gel was used for Pma1 and 10% was used for eIF2α, GST-Glc7 and GST-Sit4 detection. 
The gel can be prepared for either 0.75 or 1 mm thickness tray. Electrophoresis buffer used 
was 0.19 M Glycine, 0.1 % SDS, pH to 8.3 with Tris base. 25 A current fixed all the time 
was applied for separation of proteins of one gel. 
7.3.2. Protein detection with Coomassie Brilliant Blue R-250 
        After protein separation on SDS-PAGE, the gels were incubated for 15 minutes in 
Coomassie (0.05 % Coomassie Brilliant Blue R-250, 50 % methanol, 10 % acetic acid). 
The gel was then destained using a destaining solution (10% methanol, 10% acetic acid) 
for 1 hour up to overnight.  
7.3.3. Membrane transfer 
After being separated on the gel, proteins were transferred to nitrocellulose membrane or to 
PVDF membrane. This process was carried out in Mini-Protean 3 (BioRad) in the presence 
of Towbin buffer (14.4 g/L glycine, 2 ml 10% SDS, pH to 8.3 with Tris base, 20% 
Methanol) at 100 V for 1 hr at 4°C.  
7.3.4. Direct Blue staining of the membrane 
         In some experiment the membrane with transferred proteins was incubated for 10 
minutes in 0.008%, direct blue [(Direct Blue 71, 0.1 % in H2O diluted with washing 
solution (250 ml H2O, 200 ml absolute ethanol, 50 ml glacial acetic acid)]. Stained 
membrane was left in the washing solution for 10 min and after scanning it was destained 
by incubating in destaining solution (175 ml H2O, 250 ml absolute ethanol, 75 ml 1 M 
NaHCO3) for 5 minutes. Finally the membrane was neutralized with TBS-T (0.1 % Tween 
	  




20, 150 mM NaCl, 20 mM Tris-HCl pH 7.6) for 30 minutes then could be used to continue 
western procedures. 
7.3.5. Immunodetection of the proteins transferred to the membrane 
           After the proteins were transferred to the membrane, the membrane was blocked by 
1-5% skimmed milk in TBS-T for 1 hr with agitation.  In case of applying antibodies 
against the phosphorylated regulatory domain of Pma1, skimmed milk was substituted with 
bovine serum albumin (BSA) 1% for antibody α-pST and 5% for antibody α-pS899 also in 
this latter case, α-pS899, the blocking time was much shorter only 5-15 minutes. The 
blocked membrane was incubated (overnight, 4°C or 1 hr, RT) with the primary antibody 
prepared in the same blocking solution to the dilution mentioned in Table 4. The 
membrane was washed three times for 10 minutes each with TBS-T then it was incubated 
with the specific secondary antibody (α –rabbit Ig-HRP) prepared in the same blocking 
solution to the dilution mentioned in Table 4 for 30 minutes at room temperature, followed 
by three washings for 10 minutes each with TBS-T. Finally the detection was done using 
enhanced chemiluminescence (ECL Plus Western Blotting Detection System, Amersham 
Biosciences) and the images were taken by the imaging system [LAS-3000 (FUJI)] or by 
radioactive method. When the band intensity needed to be quantified, Image Gauge 
software was used. In cases where it was necessary to reuse the membrane, it was 
incubated for 30 minutes with agitation in stripping solution (5 ml of 1 M glycine, 1 ml of 
10% SDS, 19 ml H2O, pH adjusted to 2.5 with 12 M HCl), washed once, blocked and then 
reincubated with any desired antibody, except α- pS899, in the same way as described 
above. α-Kar2 was used in combination with α-pST or α-pS899 as a control. 






α-PeIF2α 1:2000 α –rabbit Ig-HRP 1:5000 Cell Signaling Technology 
α-eIF2α 1:500 α –rabbit Ig-HRP 1:8000 Tom Dever 
α-pST 1:2000 α –rabbit Ig-HRP 1:5000 F. Portillo 
α-pS899 1:100 α –rabbit Ig-HRP 1:5000 F. Portillo 
α-Pma1 1:10000 α –rabbit Ig-HRP 1:5000 R. Serrano 
α-GST 1:3000 α –rabbit Ig-HRP 1:5000 Santa Cruz biotechnology 
α-Kar2 1:3000 α –rabbit Ig-HRP 1:5000 F. Portillo 
	  




8. Recombinant protein expression and purification 
8.1.  GST-Glc7 protein expression and purification from E. coli (García-Gimeno et 
al., 2003)  
           Saturated culture of E. coli containing pGEX-3x-GLC7 (García-Gimeno et al., 
2003; provided by Dr. Jose R. Murguía) and also of E. coli containing pGEX-3x, as a 
negative control were used to inoculate 50 ml of LB-Ampicillin (50 µg/ml) medium with 
0.5 mM MnCl2 and it was incubated 3 hours, 200 rev/min at 37°C (OD 0.6 - 0.8). 
Expression was induced by adding 0.1-0.2 mM IPTG and incubation overnight at 25°C. 
The culture was centrifuged (5 min, 3000 rev/min, RT) and the pellet was resuspended in 3 
ml of sonication buffer (50 mM Tris-HCl pH 7.6, 0.2 mM EGTA, 150 mM NaCl, 10% 
glycerol, 0.1% Triton X-100, 2 mM DTT, 2 mM PMSF, 2 mM MnCl2). A complete mini 
protease inhibitor mixture 1 tablet [Roche Applied Science] was added for 7 ml. The cells 
were broken by sonication, three cycles for 10 seconds each at maximum intensity with 30 
seconds pause and centrifuged (20 min, 15,000 rev/min, 4°C).  
           For purification of the soluble proteins obtained, all the supernatant was added to 
the washed magnetic glutathione beads (Pierce™ Glutathione Magnetic Beads) and 
incubated (1 hr, 4°C) with rotation, then beads were harvested, washed three times with the 
same buffer and resuspended in GTED 20 (100 µL) with 2 mM MnCl2. 
8.2. GST-Sit4 protein expression and purification from yeast 
8.2.1.  Check the expression of Sit4 in Soluble fraction 
         S. cerevisiae competent cell of strain (BY4741) was transformed with pYEX 4T-1-
SIT4, and also pYEX 4T-1 (negative control). Transformants were cultured on plates of SD 
supplemented with histidine, methionine and leucine. At this stage leucine was added to 
the culture because if not the growth will be extremely slow. Saturated cultures of 5 
different transformant colonies and one colony transformed with pYEX 4T-1 were 
prepared in SD supplemented with histidine and methionine, the second culture lacked 
leucine to increase the plasmid number and consequently the protein production. 
Transformants with pYEX 4T-1-SIT4) took 3 days to reach stationary phase while the 
negative control transformants took only 1 day. After that, fresh cultures of the same 
composition were inoculated and incubated to reach exponential phase. Expression was 
induced by adding 0.5 mM CuSO4 to each flask and incubating for 2 hours. The cultures 
	  




were centrifuged (5 min, 3000 rev/min, RT) and The pellet was resuspended in 1 ml of 
lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5% glycerol, 0.1% Triton X-100, 2 
mM DTT, 0.5 mM PMSF, 2 mM MnCl2, complete protease inhibitor mixture (Roche). 
Cells were broken by the aid of sterile glass beads (0.5 mm diameter) for 3-3.5 minutes by 
vortexing in 30 sec. cycles separated by ice incubation. Cell debris were removed by 
centrifuging the homogenate (2 min, 3,000 rev/min, 4°C), soluble proteins were separated 
from insoluble ones by another centrifugation (20 min, 13,000 rev/min, 4°C) and taking 
the supernatant. Proteins were denatured by Laemmli method, and checked with antibody 
α-GST.  
8.2.2. Soluble protein fraction purification  
            For purification of the soluble proteins obtained, all the supernatant was added to 
washed glutathione Sepharose 4B (GE Healthcare, Sweden) and incubated (1 hr- 
overnight, 4°C) with rotation then slurry was harvested (5 min, 2,000 rev/min, 4°C), 
washed three times with the same buffer and resuspended in 100 µL GTED 20 (see section 
2.1.2) with 2 mM MnCl2 
9. “In vitro” dephosphorylation of Pma1 by Glc7 or Sit4 
            The purified protein fused to glutathione beads or slurry was directly distributed 
into 4 microtubes (20 µL each sample)  
 Zero 
time 
30 min 1 hr 2 hrs 
Bead or slurry - GST              1 2 3 4 
Bead GST – Glc7 or slurry GST- Sit4 5 6 7 8 
 
GTED 20 was discarded after putting the microtubes in magnetic rack, or harvesting the 
slurry by centrifugation then each one received 20 µl of a mixture of  (GTED 20 + 2 mM 
MnCl2 + protease inhibitor (1x) + 4 µg activated Pma1) followed by incubation at 30°C 
with rotation. Directly after the specific time of incubation, reaction was stopped by 
protein denaturation with 20 µL of 2x mixture of (Laemmli, protease inhibitor, PMSF) 
added to each microtube, well mixed then incubated (10 min, 42°C). Samples were 
injected in polyacrylamide gel  (2 µg total membrane protein per lane). 
	  




A portion of recombinant Glc7 and its control (GST) was kept without any further 
treatment, extracted with Laemmli to check the protein expression by staining the gel with 
Coomassie. 
10. Measurement of pH changes of yeast suspensions induced by glucose (Serrano, 
1980) 
           A stationary phase culture is used to inoculate 15 ml fresh culture (YPD or SD 
supplied with required amino acids in case of plasmid transformants) in 100 ml flask and 
incubated till reaching stationary phase. Cells were harvested, washed and resuspended in 
sterile H2O and incubated 2 hours at 200 rev/min and 30°C for starvation. Cells were 
harvested and resuspended in 2 ml of 100 mM KCl and 10 mM glycylglycine, adjusted to 
pH 4 with 1 M HCl. Calibration pulses of 100 nmol HCl were added at the beginning and 
at the end of the experiment. Proton pumping of the cells was started by addition of 50 
µmoles of glucose. A pH meter GLP22 (Crison) was used to record pH. 
11. Investigation of the effect of inhibiting PP1 by regulated expression of Glc7’ on 
Pma1 activity 
 
11.1. Determination of the best doxycycline concentration to control gene expression 
of GLC7’ 
           SD medium was supplemented with leucine, histidine, methionine and 10 µg/ml 
doxycycline to inhibit expression. S. cerevisiae strains RS-119, RS–120, RS-121 were 
tested for the best concentration of doxycycline to control GLC7’ expression. Stationary 
phase cultures were prepared as described in section 2.1.1. These cells were washed and 
resuspended in sterile distilled water then served as inocula in fresh broth containing 
different doxycycline concentrations and the growth was determined by measuring OD at 
660 nm after 18 and 22 hours. 
 
11.2. Doxycycline removal and Pma1 assay  
           Stationary phase cultures of strains RS-121 and RS-120 were prepared in the same 
medium described in 4.1 but doxycycline concentration was only 2 µg/ml. They were used 
to inoculate fresh medium and incubated till reaching exponential phase. A portion of the 
culture, 20 ml, was separated and labeled zero time. Cells were harvested, resuspended in 
0.8 ml (fresh broth with 2 µg/ml doxycycline) and incubated for 10 minutes. Doxycycline 
was removed from the rest of the cells by harvesting and washing twice with water as 
described in section 2.1.2. Cells was resuspended in SD medium without doxycycline, then 
distribute into three 100-ml flasks, 20 ml each. Each flask was incubated for a specific time 
	  




interval then cells were harvested, resuspended in 0.8 ml SD medium without doxycycline 
and incubated for 10 minutes. After the incubation period they were put in liquid N2 or 
immediately homogenized as described in section 2.1.2. Protein concentration was 
determined and ATPase activity was assayed as described in sections 2.2 and 2. 3. 
 
11.3. Investigation of inhibition of Glc7 by expression of Glc7’ under doxycycline 
promoter by detecting the phosphorylation level of eIF2α 
            Exponential phase culture of strains RS-121 was obtained just as described in 
section 11.2, and washed as described in section 2.1.2. Cells were resuspended in SD 
medium without doxycycline and a zero control with doxycycline was made. Both test and 
the control were incubated for 1.5 hr. After the incubation time, protein was extracted with 
Laemmli method (section 7.1.1) and eIF2α phosphorylation levels were detected using the 
procedures described in section 7.  
 
12. Dephosphorylation rate experiment 
           Culture preparation was carried out as described in 2.1.1. The tested strain was RS-
132 transformed with YEp24, YEp24-GLC7’, YEp352, and YEp352-GLC7’ and the 
medium was SD supplemented with adenine and histidine. Also were tested the Sit4 null 
mutant and its wild type RS-259 and they were grown in YPD. Cells were grown to late 
exponential phase. Membrane isolation was according to the method described in section 
2.1.2 except that after incubation with 2% glucose for 10 minutes and taking a sample, 
glucose was quickly removed by centrifugation (2 min, 3,000 rev/min) and cells 
resuspended in the same volume of H2O. This was followed by incubation for 10 and 20 
minutes without glucose. Then the procedures of section 2. 2. were followed to determine 
protein concentration. Extracted Pma1 samples were denatured and subjected to 
electrophoresis and immunodetection as described in section 7.  
13. Rapamycin effect on Pma1 activity 
           Culture preparation was carried out as described in section 2.1.1. The tested strain 
was RS-132 and grown in YPD till exponential phase. A sample, 25 ml, was taken as zero 
time and to the rest of the culture 500 nM rapamycin prepared in DMSO was added, and 
the culture incubated at 28°C and 200 rev/min. Equal volume samples were taken after 2, 3 
and 5 hours incubation. The membrane was isolated from the samples by the same 
procedures described in section 2.1.2 except that at the step of incubation before glucose, 
	  




the resuspended pellet of all the samples (except the zero time one) received 10 µM 
rapamycin, approximately 25 times increased concentration to compensate for the 25 times 
increased concentration of cells. The Pma1 activity was assayed as described in section 2. 
The phosphorylation level of Pma1 in these samples was compared using Laemmli method 
to denature the protein as described in section 7 and applying antibodies α-ST911,2 and 
anti total Pma1 as control. 
 14. TORC1 and TORC2 thermosensitive mutant 
            The strains used for this experiment were SH221 (tor1Δ tor2ts) and its control 
SH100. First the two strains were checked for the phenotype by growing three different 
colonies of each strain on YPD plate and incubating at 37°C and RT. Second the growth 
difference was also checked in liquid medium by inoculating fresh YPD with stationary 
phase culture, starting OD at 660 nm = 0.2, and they were incubated at 37°C and 24°C. 
Growth was monitored by measuring the OD at 660 nm after 3, 6 and 24 hours. 
            To determine Pma1 activity “in vitro” same procedures described in section 2 were 
followed. Stationary phase cultures of strains SH100 and SH221 were used to inoculate 
fresh YPD, initial OD at 660 nm = 0.2, and both were incubated at 37°C for 6 hours. The 
phosphorylation level of Pma1 in these samples was compared as described in section 7 by 
applying α-pST. As control α-Pma1 was also applied on stripped membrane and the gel 
was stained with Coomassie. 
15. Protein phosphatase assay (Garcia-Gimeno et al., 2003 and Silberman et al., 1984) 
The reaction buffer was (50 mM Tris-HCl, pH 7.5, 0.1mM EGTA, 2 mM MnCl2, 
and 1 mM DTT). p-nitrophenylphosphate disodium salt hexahydrate (PNPP) (Roche, 
Germany) (Mol.Wt = 371.1 g)  stock solution was prepared (40 mM in phosphatase buffer) 
and kept at -80. The experiment was carried out by mixing 20 µL of the sample (purified 
GST-Glc7) or negative control (purified GST) with 180 µL of PNPP 40 mM and 
incubating the mixture for 10-20 min at 30 °C. The reaction was stopped by adding 1ml 
0.5 M EDTA. The absorbance was measured at 405 nm using Microplate Reader. p-
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 RESULTS  
Typical chemical inhibitors of protein phosphatases do not affect Pma1 activity 
 In order to test the role of the yeast major type 1 protein phosphatase Glc7 on the 
activation of Pma1 by glucose metabolism, we have first tested chemical inhibition of 
protein phosphatases during the activation process. If Glc7 were involved in 
dephosphorylation of the activating site of Pma1, addition of chemical inhibitors of the 
protein phosphatase could increase phosphorylation and activate the enzyme. Okadaic acid 
and calyculin A are cell-permeable inhibitors of animal type 1 and 2A protein 
phosphatases that have been shown to increase protein phosphorylation in intact animal 
cells (Shenolikar, 1994; Haystead et al., 1989). However, these inhibitors were never used 
in yeast, where only tungstate, a non-specific phosphatase inhibitor, has been utilized 
(Rodriguez-Hernandez et al., 2012). GLC7 is an essential gene in yeast (Stark, 1996) and 
therefore any inhibitor of the encoded phosphatase should inhibit yeast growth. However, 
at the tested concentrations of 0.5 µM okadaic acid and 10 mM tungstate no inhibition of 
growth was observed and also no inhibition of Pma1 activity in cells with glucose 
metabolism (Figure 24 A and B). In the case of calyculin A growth was clearly inhibited 
but still no effect on Pma1 activity was observed (Figure 24 C and D). As the 
concentration of okadaic acid was much higher than those utilized with animal cells (0.01 
µM; Shenolikar, 1994; Haystead et al., 1989) and as Glc7 is highly homologous to animal 
type 1 protein phosphatases (Stark, 1996), it seems that okadaic acid is not permeable in 
yeast and we cannot reach conclusions with this inhibitor about the participation of Glc7 
on Pma1 regulation. In the case of calyculin A, however, the inhibitor is permeable 
because it inhibits growth but still, Pma1 activity is not affected. There is evidence in 
another yeast strain that tungstate, at the tested concentration of 10 mM, increases 
phosphorylation of the Glc7 substrate eIF2α, although it only produced a slight inhibition 
of growth (Rodriguez-Hernandez et al., 2012). Therefore we may conclude from the data 
with calyculin A and tungstate that probably Glc7 has only a minor role in regulation of 
Pma1 activity, perhaps because it affects only the Km or because other protein 
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A 
 
Glucose         +                           +                         -                           -  




Glucose         +                          +                          -                          -  
Tungstate       -                          +                           -                         + 
C                                                                             D 
 
Calyculin A             -                        + 
 
Figure 24. Specific activity of Pma1 in the total membrane fraction from cells treated 
or not with  okadaic acid (A),  tungstate (B) or calyculin A (C) and growth inhibition 
by calyculin A (D).  
 
S. cerevisiae strain RS-58 was grown to first stationary phase and harvested, washed and 
resuspended with water and incubated for 15 minutes with glucose and okadaic acid (0.5 µM) or 
tungstate (10 mM) or calyculin A (2 µM) as indicated. After isolation of total membranes, Pma1 
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Expression of a dominant-negative form of GLC7 does not affect Pma1 activity 
 Another strategy to inhibit Glc7 “in vivo” is to express a truncated gene, GLC7’, 
encoding the first 208 amino acids of Glc7 (312 in total) and which has a dominant-
negative effect by inhibiting wild type Glc7 (Wek et al., 1992; Rodriguez-Hernandez et al., 
2012). We have utilized several constructions made by G. Hueso in our laboratory with 
another truncated form encoding the first 183 amino acids of Glc7 (YEp24-GLC7’; Hueso 
et al., 2012). In addition we have made a novel construction with the original deletion of 
Wek et al. (1992) encoding the first 208 amino acids (YEp352-GLC7’ and pUN50-
GLC7’).  
 In the first place we tested GLC7’ expressed from its own promoter in single copy 
(centromeric) and in multicopy (2µ) plasmids and there was no change in Pma1 activity in 
cells with glucose metabolism either in isolated membranes (ATP hydrolysis, Figure 25) or 
in whole cells (proton extrusion, Figure 26). Under these conditions it has been observed 
increased phosphorylation of a “bona-fide” substrate of Glc7, the translation initiation 
factor eIF2α encoded by the SUI2 gene in a partially defective mutant of GCN2, encoding 
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               A 
 
Figure 25. “In vitro” Pma1 activity of yeast transformed with GLC7’ 
S. cerevisiae (A) Strain RS-58 transformed with YEp24-GLC7’ compared to its control RS-58 
transformed with YEp24. (B) Strain RS-58 transformed with YEp352-GLC7’ compared to its 
control RS-58 transformed with YEp352. Cultures were first grown in SD medium supplemented 
with leucine, histidine and adenine. Stationary phase cultures were used as inoculums in SD broth 
till reaching late exponential phase then cells were harvested and resuspended with H2O and 
processed as indicated in Materials and Methods to determine Pma1 specific activity. The 
experiment (A) was repeated three times and error bars correspond to standard error. Experiment 
(B) was repeated twice with similar results and data presented are corresponding to a typical 
experiment. 
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Figure 26. pH changes of yeast suspension induced by glucose  
 
S. cerevisiae (A) Strain RS-58 / YEp24-GLC7’ (!) compared to its control RS-58 / YEp24 (") and 
strain RS-58 / YEp352-GLC7’ (#) compared to its control RS-58 / YEp352 ( ).   (B) Strain RS-
132 / pUN50-GLC7’ (#) in comparison to its control RS-132 / pUN50 ($). Specific mg of each 
strain was suspended in 2 ml of (100 mM KCl and 10 mM glycylglycine adjusted to pH 4 with 
HCl) and the pH was recorded as described in Materials and Methods. At the times indicated in 
materials and method glucose (50 µmol) and calibration pulses of 100 nmol HCl were added. The 
maximal rate of proton pumping was (A) RS-58 / YEp24= 24.5, RS-58 / YEp24-GLC7’= 23.8,  
RS-58 / YEp352= 23.8, RS-58 / YEp352-GLC7’ =22.7 (B) RS-132 / pUN50= 8.1, RS-132 / 
pUN50-GLC7’=8.07 nmol × min-1× mg yeast-1.The experiments were made once. 
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Expression of GLC7’ under control of a doxycycline-regulated promoter  
 It has been described in yeast that when genes expressed from multicopy plasmid 
are deleterious for yeast growth the copy number of the plasmid is greatly reduced (Eraso 
et al., 1987). As Glc7 activity is essential for yeast growth, too much inhibition by GLC7’ 
in multicopy plasmid may have selected cells with low copy number and small inhibition. 
Accordingly we have utilized a system where the expression of GLC7’ is under control of 
a doxycycline-regulated promoter (Ariño and Herrero, 2003). 
 As indicated in Figures 27, 28 and 29, when the expression of GLC7’ is induced by 
removal of doxycycline the yeast growth is inhibited with two different constructs (with 
and without HA3-His6 at the C-terminus), suggesting that Glc7 is inhibited by the 
truncated protein acting as a dominant-negative of an essential enzyme. We used different 
concentrations of doxycycline as shown in the Figures (27 and 28) in order to determine 
the best concentration to be used to permit the cells to grow by inhibiting the gene 
expression and also avoiding toxic effects. The concentration selected was 2 µg/ml and it 
was used in the following experiments. 
Then we checked if Pma1 activity is affected by expression of GLC7’ and, as 
indicated in Figure 30, no change in Pma1 activity was observed with the two different 
constructs inhibiting yeast growth.  
           When the results showed such a lack of effect of Glc7’ on Pma1 activity, there was 
a slight doubt that maybe GLC7’ was not expressed under the experimental conditions. So 
in order  to confirm expression of Glc7’ we carried out a semiquantitative RT-PCR from 
strain BY4741 transformed with PCM262-GLC7' before and after doxycycline removal. 
As indicated in the Figure 31 the gene did get expressed after 1.5 hours incubation of the 
cells in absence of doxycycline. These data are in agreement with our previous conclusion 
that Glc7 protein phosphatase is minorly involved or it is not the only phosphatase 
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Figure 27. Effect of different doxycycline concentrations (0-20 µg/ ml) on growth of S. 
cerevisiae  strains derived from BY4741 by transformation with different plasmids. 
(A) strain RS-119 (transformed with PCM262) (B) strain RS-120 ( transformed with 
PCM262-GLC7’-HA3-His6) (C) strain RS-121(transformed with PCM262- GLC7’). 
 
S. cerevisiae cells were grown in SD medium supplemented with leucine, histidine, methionine and 
doxycycline 10 µg/ ml. Stationary phase  cultures were washed twice and resuspended with sterile 
distilled water and used as inoculums  in fresh medium of the same complosition with different 
doxycycline concentrations. Growth was then determined by measuring optical density (OD) after 
incubation at 30°C with shaking 200 rev/min for 18 (") and 22 ( ) hours. The experiment was 
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Figure 28. Effect of different doxycycline concentrations (0-5 µg/ ml) on growth of S. 
cerevisiae strains derived from BY4741 by transformation with different plasmids. 
(A) strain RS-120 (transformed with PCM262-GLC7’-HA3-His6) (B) strain RS-121 
(transformed with PCM262- GLC7’). 
Conditions and symbols as in Figure 27 but with lower range of doxycycline concentrations. The 
experiment was made once.  
 
 
Figure 29. Inhibition of growth of cells expressing GLC7’ on solid medium in absence 
of doxycycline. 
 
S. cerevisiae strain RS-119 (strain BY4741 transformed with PCM262) and strain RS-121 (strain 
BY4741 transformed with PCM262-GLC7’) were grown in SD medium supplemented with 
leucine, histidine, methionine and doxycycline (2 µg/ml) till stationary phase, harvested, washed 
and resuspended with sterile distilled water same volume . Two dilutions ( 1/20 and 1/200) were 
made and 3 µL of each dilution were spotted on a plate of the same medium. The experiment was 
repeated twice with similar results. 
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Figure 30. Lack of effect of doxycycline removal on Pma1 activity of strains RS-120 
(strain BY4741 transformed with PCM262-GLC7’-HA3-His6) and  RS-121 (strain 
BY4741 transformed with PCM262- GLC7’).  
S. cerevisiae cultures were first grown in SD medium supplemented with leucine, histidine, 
methionine and doxycycline (2 µg/ml). Stationary phase cultures of strains RS-120 ( ) and RS-
121(") were used as inoculums in SD fresh broth with the same composition till reaching 
exponential phase then cells were harvested, washed  and resuspended with the same medium 
without doxycycline. At indicated times, samples were processed as indicated in Materials and 
Methods to determine Pma1 specific activity. The experiment with strain RS-120 was repeated 
twice, and with strain RS-121 for 5 times and measured once in galactose medium and the 
repetitions gave similar results and data presented are corresponding to a typical experiment. 
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                                             UBC6 primers                                  GLC7’ primers 
 
Figure 31. Semi quantitative RT-PCR analysis of expression of GLC7’ in RS-121 
(strain BY4741 transformed with PCM262-GLC7’) before and after removal of 
doxycycline. 
(A) Semi quantitative RT-PCR with GLC7’ primers of samples taken after 1.5 and 2 hours 
incubation of exponential phase cultures in presence (+) or in absence (-) of doxycycline (2 µg/ml). 
The amplified GLC7’ fragment has 227 bp. (B) Control experiment using  UBC6 primers on all the 
samples to check that the expression of genes other than GLC7’ is not affected. (C) Control 
experiment, GLC7’ primers are specific because no product is amplified in a sample from yeast not 
transformed with a GLC7’ plasmid. One of the primers corresponds to a flanking sequence of the 
plasmid.  On the other hand  UBC6 primers result in amplification. The used marker is pBR322-
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Expression of a dominant-negative form of GLC7 does not affect dephosphorylation 
of Pma1 after removal of glucose  
 One further strategy to investigate if protein phosphatase Glc7 participates in the 
regulation of Pma1 has been to determine if inhibition of Glc7 by expression of a truncated 
dominant-negative form of the enzyme affects the dephosphorylation of the regulatory 
domain of Pma1 after removal of glucose from the yeast medium. If Glc7 
dephosphorylates this regulatory domain its inhibition should result in slower 
dephosphorylation after removal of glucose from the medium.  
Recently, the group of Francisco Portillo at Madrid has developed specific 
antibodies against the two phosphorylated sites in the regulatory domain of Pma1 modified 
by glucose metabolism (Mazón et al., 2015). Antibody α-pS899 specifically recognizes 
phosphorylated Ser899, which slightly contributes to Pma1 activation by increasing the 
affinity of the enzyme for ATP. Antibody α-pST specifically recognizes the double 
phosphorylation on Ser911 and Thr912 that is the major regulatory event by increasing the 
maximal activity of the enzyme. By using these two antibodies we could show that 
expression of the dominant-negative form of Glc7 has no effect on the rate of 
dephosphorylation of Pma1 after removal of glucose from the medium of the cells (Figure 
32). In the same figure it is clear that the phosphorylation level of Pma1 increases after 
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Figure 32. Effect of GLC7’ on the  “in vivo” dephosphorylation rate of Pma1 
phosphorylation site Ser899 (A) and Ser 911 Thr 912(B)  
S. cerevisiae strain RS-132 transformed with YEp352-GLC7’ compared to its control RS-132 
transformed with YEp352, also RS-132 transformed with YEp24-GLC7’ compared to its control 
(RS-132 transformed with YEp24). Late exponential phase cultures were harvested, washed and 
resuspended with sterile distilled water and incubated  for 15 minutes (-), then incubated with 
glucose for 10 minutes (+), glucose was removed by centrifugation then cells were incubated in 
water for 10 and 20 minutes as indicated. The levels of phosphorylated serine 899 (pS899) (A) and 
double phosphorylation at serine 911 and threonine 912 (pST) (B) were determined by western 
blotting as described in Materials and Methods. α-Kar2 was used as control of loading. The bands 
recognized by the antibodies represent Pma1 of 100 KD and Kar2 of 75 KD. The experiment was 
repeated twice with similar results. 
 
 
Phenotype of GLC7’ transformants with hygromycin B and acetic acid 
 
Any activation of Pma1 by increased phosphorylation of the regulatory sites should 
manifest by increased tolerance to acetic acid and decreased tolerance to toxic cations such 
as hygromycin B (Hueso et al., 2012). Yeast cells with a more active Pma1 should 
maintain a more neutral intracellular pH after treatment with acetic acid because of 
increased capability for proton extrusion. Also, these cells should have a hyperpolarized 
membrane potential and therefore a decreased tolerance to toxic cations such as 
hygromycin B whose uptake is driven by membrane potential (Perlin et al., 1989; 
Goossens et al., 2000). As indicated in Figure 33 GLC7’ expressing cells have a slightly 
less tolerance to hygromycin but this phenotype is not very significant. On the other hand 
no phenotype of tolerance to acetic acid could be observed (Figure 34). Therefore again we 
conclude that Glc7 is minorly involved (or it is not the only phosphatase involved) in 
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Figure 33. Effect of GLC7’ on hygromycin B resistance. 
S. cerevisiae (A) Strain RS-132 transformed with pUN50,  pUN50-GLC7’, YEp352-GLC7’. (B) 
Strain RS-132 transformed with YEp24, YEp24-GLC7’. Serial dilutions of stationary phase 
cultures of these strains prepared in SD,  were incubated on YPD media for 2–3 days at 30°C. The 
experiment was made once with 5 different colonies of RS-132 /  pUN50-GLC7’ and 6 different 




Figure 34. Effect of GLC7’ on acetic acid resistance. 
S. cerevisiae strain RS-132 transformed with pUN50 ,  pUN50-GLC7’, YEp352, YEp352-GLC7’. 
Serial dilutions of stationary phase cultures of these strains prepared in SD, were incubated on 
YPD media of pH  3.5 ,  for 2–3 days at 30°C. The experiment was repeated twice with similar 
results. 
 
Mutants in GLC7 exhibit altered ion homeostasis 
 Another approach to investigate the role of Glc7 in Pma1 activity has been to 
determine this activity in mutants of the GLC7 gene previously identified in the laboratory 
of Kelly Tatchell (Baker et al., 1997; Williams et al., 2002). Protein phosphatases exhibit 
little substrate specificity “in vitro” while the specificity “in vivo” is dictated by regulatory 
subunits that target the phosphatase catalytic subunit to its phosphorylated protein substrate 
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(Cohen, 1989; Stark, 2004). One of the functions of Glc7 is to promote glycogen synthesis 
by dephosphorylating and activating glycogen synthase 2 (Gsy2) as cells approach 
stationary phase. The glc7-1 mutant is defective in interacting with the required regulatory 
subunit for this function, Gac1, and accumulates little glycogen (Stark, 2004). The glc7-
109 and glc7-132 mutants were isolated by directed mutagenesis of clusters of charged 
residues that could mediate interactions with regulatory subunits (Baker et al., 1997). The 
glc7-109 mutant exhibits increased glycogen accumulation while the glc7-132 mutant 
resembled the glc7-1 mutant in accumulating less glycogen. Interestingly, the glc7-109 
mutant, but not the other two, is more sensitive to toxic cations such as Na+, Li+ and 
hygromycin B and has a greater membrane potential (Williams-Hart et al., 2002). The 
activity of Pma1, however, was not affected. 
We have reinvestigated the sensitivity of these mutants to acetic acid and toxic 
cations (Figure 35). The results indicate that glc7-1 and glc7-132 are more tolerant than 
wild type to acetic acid, glc7-109 is more sensitive than wild type to acetic acid and the 
three mutants are more sensitive than wild type to lithium and hygromycin B. These 
phenotypes are difficult to explain in terms of changes of Pma1 activity. Determinations 
“in vitro” and “in vivo” (Figure 36) indicate that the glc7-1 mutant exhibits a slight 
increase in Pma1 activity with respect to wild type both “in vivo” and “in vitro” while the 
other two mutants had no change in the “in vitro” assay, while glc7-132 has increased rate 




Figure 35. The growth phenotypes of 3 glc7 mutants.  
S. cerevisiae WT (strain KT1112) and mutants, glc7-1, glc7-132 and glc7-109 serial dilutions of 
stationary phase cultures were incubated on the indicated agar medium for 2–3 days at 30°C. The 
experiment was repeated twice with similar results. 
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Figure 36. Pma1 specific activity of 3 GLC7 mutants. (A) “In vitro” activity (B) pH 
changes of yeast suspension induced by glucose.  
(A) S. cerevisiae stationary phase cultures were used as inoculums in YPD broth till reaching 
stationary phase and  then cells were harvested and resuspended with H2O then processed as 
indicated in Materials and Methods to determine Pma1 specific activity. (B) Wild type (strain 
KT1112) ("), glc7-1 (#), glc7-109  ( ) and glc7-132 (!) specific mg of each strain was 
resuspended in 2 ml of (100 mM KCl and 10 mM glycylglycine adjusted to pH 4 with HCl) and the 
pH was recorded as described in Materials and Methods. At the times indicated in Materials and 
Methods, glucose (50 µmol) and calibration pulses of 100 nmol HCl were added. The maximal rate 
of proton pumping was (A) wild type= 20.03, glc7-1= 27.2,  glc7-109= 21.1, glc7-132 =32.5 nmol 
× min-1× mg yeast-1. The experiment (A) was repeated three times and error bars correspond to 
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Effect of expression of a dominant-negative form of GLC7 and of glucose metabolism 
on phosphorylation of eIF2α  
 The translation factor eIF2α  is a known substrate of Glc7 and is phosphorylated by 
protein kinase Gcn2 in response to amino acid starvation (Wek et al. 1992). We have 
tested the effect of glucose metabolism and of expression of the truncated dominant-
negative form of Glc7 on the phosphorylation level of eIF2α. As indicated in Figures 37 
and 38, glucose metabolism greatly increases eIF2α phosphorylation, as it also does in the 
case of Pma1 phosphorylation at Ser911 Thr912 (Mazón et al., 2015). However, in a 
mutant with constitutive activity of Gcn2 (Menacho-Marquez et al., 2007) eIF2α  
phosphorylation was high in the absence and presence of glucose. GCN2 is not known to 
be activated by glucose metabolism and therefore it could be that glucose inhibits Glc7. 
Figure 37 also shows the results of a comparison that we made between three different 
methods of protein extraction for SDS-PAGE.  It was reported by Wright et al. (1989) that 
TCA method is the best and that it produces much higher protein amount. Our results 
indicated that the two other methods tested (Laemmli and alkaline lysis) produce almost 
equal amounts of protein like the tedious, more time consuming than TCA method that 
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Figure 37. Comparison between three methods of protein extraction. 
(A) Western blotting with antibodies against P-eIF2α (B)  Western blotting with 
antibodies against total eIF2α (C) Direct blue stained membrane.   
 
S. cerevisiae strain RS-259 stationary phase cultures were used as inoculums in YPD broth till 
reaching early exponential phase then cells were harvested, washed and resuspended with H2O  
then distributed into 6 samples, glucose was added to only 3 of them  and incubated all for 10 
minutes. Extraction was made  by : harvesting the cells then boiling  with hot Laemmli 1X for 10 
minutes at 100°C or hot NaOH or precipitated by TCA as mentioned in details in Materials and 
Methods. Standard protein markers (PageRuler Prestained Protein Ladder, from Thermo 
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                  C 
                     
Figure 38. Glucose effect on phosphorylation level of eIF2α in (A) wild type yeast 
(BY4741) and (B) GCN2c mutant 
Western blotting with antibodies against PeIF2α and, as control of loading: antibody against total 
eIF2α and Direct blue stained membrane.  S. cerevisiae strain RS-259 and GCN2c mutant stationary 
phase cultures were used as inoculums in YPD broth till reaching early exponential phase then cells 
were harvested, washed and resuspended with H2O  then distributed into (5 ml) samples, 2% 
glucose was added or not and all were incubated for 10 min. Extraction was made by Laemmli as 
described in materials and method. The experiment was repeated three times with similar results. 
The band intensity was quantified by Image Gauge software then relative band intensity (P-
eIF2α/total eIF2α) was calculated and the average value was represented in (C) with arbitrary units 
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In order to check if inhibition of Glc7 by Glc7’ increases phosphorylation of eIF2α, 
we expressed Glc7’ under control of doxycycline and, as indicated in Figure 39, inhibition 
of Glc7 by expression of the truncated Glc7’ had no effect on eIF2α  phosphorylation. 
Therefore, even in a system where the Glc7 phosphatase is known to regulate the 
phosphorylation level of a protein substrate, inhibition of Glc7 by the truncated dominant-
negative form does not increase phosphorylation.  
                         A 
 
                                              B 
              
 Figure 39. Inducing expression of GLC7’ has no effect on phosphorylation level of 
eIF2α. 
(A)Western blotting with antibodies against PeIF2α and as control of loading: antibody against 
total eIF2α and Direct blue stained membrane. S. cerevisiae strain  RS-121 was grown in SD 
medium supplemented with leucine, histidine and methionine and doxycycline (2 µg/ml) till 
reaching exponential phase then doxycycline was removed and samples incubated for one hour and 
a half with or without doxycycline. True zero control with doxycycline was made. The experiment 
was repeated three times with similar results. The band intensity was quantified by Image Gauge 
software then relative band intensity (P-eIF2α/total eIF2α) was calculated and the average value 
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Effect of sit4 null mutation on the activity of Pma1  
sit4 null mutant is viable, so we used it in order to test the effect of Sit4, which is 
type 2A protein phosphatase, on Pma1 activity. We tested the rate of dephosphorylation of 
activated Pma1 of sit4 null mutant in comparison to the wild type. Results in Figure 40 
showed that the dephosphorylation rate of the mutant was slower, yet the level of 
phosphorylation after glucose addition was less than in the wild type. 
 
Figure 40. Dephosphorylation rate of Pma1 (A) wild type (strain BY4741) and  (B) sit4 null 
mutant. 
 S. cerevisiae late exponential phase cultures were harvested, washed and resuspended with sterile 
distilled water then incubated  for 15 minutes (-), then glucose was added and cells were incubated 
for 10 minutes (+), glucose was removed by centrifugation then cells were incubated in water for 
10 and 20 minutes as indicated. The levels of double phosphorylation at serine 911 and threonine 
912 (pST) were determined as described in Materials and Methods. Coomassie stained gel is 
presented as control of loading. The bands recognized by the antibody and stained by Coomassie 
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In another approach to test the effect of Sit4 on Pma1 activity we measured the “in 
vitro” activity of Pma1 of the same samples used in dephosphorylation rate experiment, of 
both the sit4 null mutant and the wild type. As indicated in Figure 41 the wild type showed 
higher Pma1 activity after glucose activation than that of the null sit4 mutant. 
 
 
Figure 41. Effect of sit4 null mutation on specific activity of Pma1. 
 S. cerevisiae strain RS-259 (#) and null sit4 mutant ( ) late exponential phase cultures were 
harvested, washed and resuspended with sterile distilled water then incubated  for 15 minutes (-), 
then incubated with glucose for 10 minutes (+), glucose was removed by centrifugation then cells 
were incubated in water for 10 and 20 minutes as indicated. The crude Pma1 was extracted and its 
specific activity was determined as described in materials and method. The experiment was 
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The sit4 null mutant also showed lower Pma1 activity when the pH changes of 
yeast suspension induced by glucose were measured, the maximal rate of proton pumping 
of the wild type was almost twice that of the null mutant as shown in Figure 42. All these 
results together suggest that Sit4 is having a stimulatory effect on Pma1 activity. 
 
 
Figure 42. pH changes of yeast suspension induced by glucose. 
 
S. cerevisiae strain RS-259 (!) and null sit4 mutant (#) . Specific mg of each strain was suspended 
in 2 ml of (100 mM KCl and10 mM glycylglycine adjusted to pH 4 with HCl) and the pH was 
recorded as described in Materials and Methods. At the times indicated in materials and method 
glucose (50µmol) and calibration pulses of 100 nmol HCl were added. The maximal rate of proton 










	   72	  
We tested the effect of LiCl and hygromycin B on growth of sit4 null mutant. In 
Figure 43, we can see that null sit4 mutant is showing  less growth in presence of  LiCL 
and hygromycin than the wild type, yet the growth of the null mutant is already much 
lower in absence of any toxic cation, on YPD, as an effect of the null mutation on growth 




Figure 43. The growth phenotypes of sit4 null mutant in comparison to its wild type. 
  
S. cerevisiae strains RS-259 (WT) and sit4 null mutant serial dilutions of stationary phase cultures 

















	   73	  
“In vitro” dephosphorylation of Pma1 by Glc7 
            We have tested if the Glc7 phosphatase could dephosphorylate or not Pma1 “in 
vitro”. In order to do that we used a construction of Glc7 fused to GST (pGEX-3X-GLC7) 
to express the protein in E. coli then we purified it with glutathione beads. The presence of 
purified protein in the soluble fraction after inducing the expression with IPTG was 
confirmed by staining the membrane with Coomassie, Figure 44.  
To test the “in vitro” interaction between Glc7 and Pma1, the purified Glc7 was 
incubated with activated Pma1 for different time intervals. Figure 45A showed that the 
level of the double phosphorylation at serine 911 threonine 912 of Pma1 decreased after 
being incubated with Glc7. A control experiment was conducted simultaneously (Pma1 
incubated with purified GST extracted from cells harboring pGEX-3X induced with IPTG) 
and as shown in Figure 45B the phosphorylation level of Pma1 at ST911, 2 in this control 
experiment was constant at different time intervals of incubation, which confirms that Glc7 
“in vitro” dephosphorylates Pma1. 
 
“In vitro” dephosphorylation of Pma1 by Sit4 
 
           In order to test the ability of Sit4 to dephosphorylate Pma1 “in vitro” we used a 
pYEX 4T-1-SIT4 construct, which can express the protein in the soluble fraction in yeast. 
The expression was confirmed with anti-GST antibody after expression induction with 
CuSO4, Figure 46. The purified Sit4 was incubated with activated Pma1 for different time 
intervals. Figure 47A shows that Sit4 can dephosphorylate Pma1 “in vitro” as the 
phosphorylation level at serine 911 threonine 912 decreased after incubation with Sit4, 
starting from 30 minutes incubation and decreasing more with increased incubation time. 
A control experiment was conducted simultaneously  (Pma1 incubated with purified GST 
extracted from cells harboring pYEX 4T-1 induced with CuSO4) and as shown in Figure 
47B the phosphorylation level of Pma1 at serine 911 threonine 912 in this control 
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Figure 44. Expression of recombinant Glc7 protein from pGEX-3X vector in 
Escherichia coli.  
RS-405 strain (E. coli transformed with pGEX-3X-GLC7) and a control strain (E. coli transformed 
with pGEX-3X). The cells were grown to exponential phase at 37°C and then induced with IPTG 
(see“Materials and Methods”). The cells were harvested, sonicated and the soluble materials were 
purified with Pierce™ Glutathione Magnetic Beads, then subjected to SDS-PAGE and stained for 
protein with Coomassie. Lane 1 marker (Precision Plus Protein Dual Color Standards) from 
BioRad; lane 2, a fraction from the control cells (harboring pGEX-3X) induced with 0.1- 0.2 mM 
IPTG; Lane 3 a fraction from cells harboring pGEX-3X-GLC7 induced with 0.1- 0.2 mM IPTG. 
The upper arrow refers to GST-Glc7 in correct position Glc7 (35.9) + GST (26) = 61 KD. The 
experiment was made once. 
 
 
Figure 45. Purified Glc7 shows “in vitro” effect on activated  Pma1. 
 
E. coli (A) RS-405 strain (transformed with pGEX-3X-GLC7) and (B) a control, strain E. coli 
DH5α transformed with pGEX-3X. The cells were grown to exponential phase at 37°C and then 
induced with IPTG (see “Materials and Methods”).  The cells were harvested, sonicated and the 
soluble materials were purified with Pierce™ Glutathione Magnetic Beads. The purified soluble 
protein was incubated with activated Pma1 at 30°C for the specified times then membrane proteins 
were analyzed by Western blotting with antibodies against phosphorylated Ser899 (pS899) and α-
Kar2 as control of loading, as described in materials and method. The bands recognized by the 
antibodies represent Pma1 of 100 KD and Kar2 of 75 KD. The experiment was made once. 
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Figure 46. Expression of recombinant Sit4 protein from the pYEX 4T-1 vector in 
Saccharomyces cerevisiae.  
S. cerevisiae strain (RS-259 transformed with pYEX 4T-1-SIT4) and a control strain (RS-259 
transformed with pYEX 4T-1). The cells were grown to exponential phase at 28°C and then 
induced with CuSO4 0.5 mM (see “Materials and Methods”). The cells were harvested and broken 
with the aid of glass beads in specific lysis buffer then soluble material membrane proteins were 
analyzed by Western blotting with antibodies against GST. Lanes 1 to 5, fractions from cells 
harboring pYEX 4T-1-SIT4 after induction with CuSO4 0.5 mM ; lane 6, a fraction from the 
control cells (harboring pYEX 4T-1) induced with CuSO4 0.5 mM. The upper arrow refers to GST-
Sit4 in correct position Sit4 (35.9) + GST (26) = 61 KD. Standard protein markers (PageRuler 
Prestained Protein Ladder, from Thermo Scientific), with masses indicated in kDa was 
used. The experiment was made once. 
 
 
Figure 47. Purified Sit4 shows “in vitro” effect on activated  Pma1. 
 
S. cerevisiae strain (A) RS-259 transformed with pYEX 4T-1-SIT4 and (B) a control, strain RS-259 
transformed with pYEX 4T-1. The cells were grown to exponential phase at 28°C and then induced 
with CuSO4 0.5 mM (see “Materials and Methods”). The cells were harvested and broken with the 
aid of glass beads in specific lysis buffer. The soluble materials were purified with (Glutathione 
sepharose TM 4B (GE Healthcare) Sweden). The purified soluble protein was incubated with 
activated Pma1 at 30°C for the specified times then membrane proteins were analyzed by Western 
blotting with antibodies against the double phosphorylation at serine 911 and threonine 912 (pST). 
Coomassie stained membrane is presented as control of loading, procedures are described in 
materials and method. The bands recognized by the antibody and stained by Coomassie represent 





	   76	  
 
TOR kinase is a positive regulator of Pma1 activity 
 
           The idea now was to take another direction and test the effect of one of the most 
important kinases of eukaryotic cells, TOR, on Pma1 activity. Rapamycin is known to 
inhibit TORC1 so our first approach was to test the effect of rapamycin on Pma1 activity. 
In order to do that we first had to determine which concentration of rapamycin will give 
good inhibition of TORC1, and as the latter is necessary for growth, the effect of 
rapamycin was measured by OD of growing cultures.  Figure 48 shows that higher 
concentrations of rapamycin are inhibiting TORC1, as represented by inhibition of growth.  
 
   
Figure 48. Effect of rapamycin different concentrations on TOR Kinase shown in 
terms of yeast growth inhibition  
S. cerevisiae strain RS-132 was inoculated in YPD with initial OD at 660 nm =  0.1 with the 
specified rapamycin concentration (0, 0.1, 1, 10, 100 nM) and incubated (30°C, 200 rev/min). 
Growth was detected by measuring OD at 660 nm at zero time (#), again after 8 hours ( ) and 










































Rapamycin	  concentration	  (nM)	  
RESULTS 
	   77	  
The next step was to treat the cells with rapamycin and this was made at two stages: 
in the growth medium (0.5 µM) and during treatment of cells with glucose (10 µM). The 
concentration of this drug had to be increased in order to keep the ratio of rapamycin to 
cells in the procedures of the experiment. In the experiment of Figure 48 rapamycin was 
added to cells at an OD = 0.1, while for Pma1 activity the culture was at about OD = 2 and 
after concentrating cells for incubation with glucose OD was about 40. 
When the activity of Pma1 was measured “in vitro” after incubation with 
rapamycin for different time intervals, it showed a high decrease completed in two hours 
(Figure 49A). The same decrease was confirmed when the phosphorylation level of these 
samples was measured using α-pST (Figure 49B). Total Pma1 protein on the other hand 
did not show any change of amount when tested with the specific antibody, which means 
that the effect on activity is not explained by decreased amount of the enzyme. 
Still in the same direction, testing the effect of TOR kinase on Pma1 activity, the 
second approach was to measure Pma1 activity in a strain that is TORC1 and TORC2 
thermosensitive, SH221 (tor1Δ tor2ts) in comparison to its control strain (SH100) 
(Helliwell et al., 1998). First to confirm the phenotype, Figure 50A shows the different 
growth of the	  thermosensitive and control strain at non-permissive temperature (37°C) on 
YPDA: while the control strain could grow normally, the tor1Δ tor2ts mutant could not 
grow. The same difference is confirmed in terms of OD when the strains were grown in 
broth (Figure 50B). Both strains grew equally at room temperature (Figure 50C). 
After finding good difference in growth between the two strains after 6 hours 
incubation at 37°C, this time interval was used in the following experiment. Figure 51A 
shows the decreases of Pma1 “in vitro” activity in SH221 strain in comparison to its 
control strain (SH100) at non-permissive temperature. Such a decrease was confirmed by 
measuring the phosphorylation level of the same samples using α-pST (Figure 51B). These 
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Figure 49. Rapamycin decreases Pma1 activity. (A) “in vitro” Pma1 specific activity 
of cells treated with rapamycin and (B) phosphorylation level of Pma1 of the same 
samples.  
 
S. cerevisiae strain RS-132 exponential phase cultures were incubated with rapamycin 500 nM at 
30°C, 200 rev/min for the indicated time intervals. At each time interval cells were harvested, 
washed resuspended with H2O and rapamycin was added to final concentration of 10 µM and 
mixed well by vortex. The suspension was proceeded to extract the Pma1. (A) Pma1 specific 
activity (") was assayed “in vitro” as described in materials and method. (B) The same extracted 
membrane proteins were analyzed by western blotting with antibodies against the double 
phosphorylation at serine 911 and threonine 912 (pST) and against total Pma1. Coomassie stained 
membrane is presented as control, procedures are described in Materials and Methods. The bands 
recognized by the antibody and stained by Coomassie represent Pma1 of 100 KD. The experiment 
(A) was repeated three times and	  and error bars correspond to standard error and experiment (B) 
was repeated twice with similar results. 
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Figure 50. Growth difference between tor1Δ  tor2ts and its control strain at 37°C and 
at room temperature.  
 
S. cerevisiae strain SH221 (#)	  and its control strain SH100 (!) were cultured on YPDA plate (A), 
three different colonies of each strain and incubated at 37°C for two days. stationary phase culture 
of one transformant from each strain was inoculated in fresh YPD broth with starting OD of 0.2 
then incubated at 37°C (B) or at room temperature (C) and growth was determined by measuring 
OD at different time intervals. The experiments were made once. 
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Figure 51. Decrease of Pma1 activity of tor1Δ tor2ts strain when grown at non-
permissive temperature. 
   
S. cerevisiae strain SH221 and its control strain SH100, stationary phase cultures were inoculated 
in fresh YPD broth with starting OD of 0.2 and incubated at 37°C for 6 hours. cells were harvested 
and resuspended with H2O and processed to extract the Pma1. (A) specific activity of the extracted 
Pma1 was assayed “in vitro”. (B) The same extracted Pma1 samples were analyzed by western 
blotting with antibodies against the double phosphorylation at serine 911 threonine 912 (pST) and 
also against total Pma1. Coomassie stained membrane is presented as control. Procedures are 
described in materials and method. Standard protein markers (PageRuler Prestained Protein 
Ladder, from Thermo Scientific), with masses indicated in kDa was used.  Both experiments (A) 
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  DISCUSSION  
Lack of effect of typical chemical inhibitors of protein phosphatases on Pma1 
activity 
 Okadaic acid and calyculin A are potent inhibitors of type 1 protein 
phosphatases (PP1) in all mammalian cells because they are permeable. In yeast Glc7 is 
the most important PP1, it is essential for growth and it has been connected to ion 
homeostasis. However, when these inhibitors, and also tungstate, were added to a yeast 
culture there was no effect on Pma1 activity (Figure 24). As no inhibition of growth was 
observed in case of treatment with okadaic acid and as Glc7 is an essential enzyme, it is 
likely that this inhibitor has poor uptake in yeast. In case of calyculin A there was a 
significant growth inhibition, shown in Figure 24D. Pma1 activity of cells treated with 
calyculin A was slightly higher than in non-treated cells. Yet, we cannot conclude that 
Glc7 inhibition activates Pma1 because the observed increase is very small (about 10%) 
and the experiments were only done once as the results were disappointing. Both 
okadaic acid and calyculin A are hydrophobic compounds and their uptake by cells is 
affected by many things like the partitioning to cell membrane and also from the 
membrane to the cytoplasm and they might have needed much longer time in order to 
be well absorbed as stated by Swingle et al. (2007). Also the different compounds do 
not necessarily diffuse into cells at the same rate, especially if the compounds are added 
at different concentrations and finally, because organic anion efflux pumps may use 
these compounds as substrates (Swingle et al., 2009). On the other hand, tungstate is 
water-soluble and at the concentration we used in the experiment (10 mM) it is reported 
to give a very high inhibition of Glc7 activity (Rodriguez-Hernandez et al., 2012). 
These considerations indicate that chemical inhibitors of Glc7 have no effect on Pma1 
activity and that other methods should be used to reach definitive conclusions. 
 
Effect of expression of a dominant-negative form of GLC7 on Pma1 activity 
           As Glc7 is an essential enzyme, a null mutant could not be tested. Truncated 
Glc7 (Glc7’) is reported to have a dominant negative effect, partially inhibiting wild 
type Glc7, (Wek et al., 1992).  Constitutive expression of Glc7’ driven by its genomic 
promoter had no effect on Pma1 activity “in vitro” using a multicopy plasmid (Figure 
25). The same lack of effect of expressing Glc7’ on Pma1 activity was noticed when the 
activity was measured  “in vivo”, when the GLC7’ gene was expressed from multicopy 
or centromeric plasmids (Figure 26). We also tried to measure the effect of GLC7’ using 
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a slightly different method because we thought the kinase effect on Pma1 may be so 
high under glucose addition that it masks any possible effect of the phosphatase. We 
removed the glucose after 10 minutes activation to measure the dephosphorylation rate 
with antibody against phosphorylated Ser899 and also against the double 
phosphorylation at Ser911 and Thr912 (Mazón et al., 2015), and again even with this 
indirect approach there was no effect on Pma1: the dephosphorylation rate after removal 
of glucose in the cells transformed with GLC7’ was the same as in those transformed 
with empty plasmid (Figure 32).  
When these transformants were tested for resistance to hygromycin B they 
showed a little more sensitivity than wild type (Figure 33). In the same experiment, we 
noticed that putting GLC7’ on high copy number plasmid does not produce higher 
effect than putting it on centromeric plasmid. On the other hand, when those 
transformants were tested for acetic acid resistance no change of tolerance was observed 
with respect to the control strain (the same strain transformed with empty plasmid) 
(Figure 34). An increase in Pma1 activity should have resulted in improved tolerance to 
intracellular acidification induced by acetic acid.  Because Pma1 activity was not 
affected (measured either “in vivo” or “in vitro”) the small effect on hygromycin 
tolerance could be due to an effect of Glc7’ on potassium transporters (Trk1, Trk2) that 
are regulated by Hal4 and Hal5 kinases according to Mulet et al. (1999). When these 
genes are disrupted this leads to greater cation sensitivity and increase the membrane 
potential. Another explanation could be that Glc7 directly affects the channels involved 
in hygromycin transport. 
 
Expression of GLC7’ under control of a doxycycline-regulated promoter  
As the continuous expression of Glc7’ may be deleterious to cells and selections 
of non-expressing mutants could have occurred, a truncated form of Glc7 under control 
of a doxycycline-regulated promoter was used. When Glc7’ was conditionally 
expressed growth was inhibited (Figure 27, 28, 29) because Glc7 is a vital protein for 
cell growth and with such high expression of a dominant negative gene cells cannot 
grow. Cells were allowed to grow in the presence of a selected concentration of 
doxycycline until exponential phase and then were incubated in a medium free from 
doxycycline to induce Glc7’ expression. The activity of Pma1 was assayed “in vitro” 
after different time intervals and there was no effect on Pma1 activity in the two 
constructs used (with and without HA3-His6 at the C-terminus; Figure 30). The 
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expression of the GLC7’ gene, suggested by the observed growth inhibition, was 
confirmed by semi quantitative RT-PCR and as shown in Figure 31. These results 
confirm the previous results with constitutive expression of GLC7’ and suggest that 
inhibition of Glc7 has a minor effect on Pma1 activity probably because it is involved in 
the dephosphorylation of S899 which is related to Pma1 Km (Mazón et al., 2015). 
 
 Mutants in GLC7 exhibit altered ion homeostasis 
 Some Glc7 mutants were tested for Pma1 activity and the results showed that 
glc7-1 and glc7-132, reported to have decreased glycogen accumulation and less Glc7 
activity, both had a higher rate of proton extrusion from cells (higher “in vivo” Pma1 
activity) (Figure 36B), higher tolerance to acetic acid and lower tolerance to 
hygromycin B and LiCl (Figure 35). This may suggest that these glc7 mutations 
increase Pma1 activity but when the activity was assayed “in vitro” in isolated 
membranes only glc7-1 exhibited slightly higher Pma1 activity while glc7-132 did not 
show any increase (Figure 36A). On the other hand a third mutant, glc7-109, reported to 
have a dominant, hyperglycogen defect and that was expected to have a lower Pma1 
activity and consequently higher sensitivity to acetic acid, it did show the latter effect 
but when the activity of Pma1 was assayed it was almost equal to the wild type, both “in 
vitro” and “in vivo”. Also, glc7-109 was expected to have lower sensitivity to 
hygromycin and LiCl, yet it acted in an opposite direction showing higher sensitivity to 
both of them. Some of these phenotypes of glc7-109 were already tested by Williams-
Hart T et al. (2002) and are in agreement with our results. So if we tried to make some 
conclusions about such results with phenotypes of tolerance to toxic cations and acetic 
acid going in unexpected directions, it seems that the mechanism is not clear and it 
could be that glc7 mutations affected the transport system of these cations and acetic 
acid. When the Pma1 activity was assayed “in vitro”, it was equal to wild type (glc7-
132 and glc7-109) yet there were effects on acetic acid and toxic cation tolerance. It 
could be that the effect of these Glc7 mutations is not on Pma1 but for example on 
potassium transporters (see above). Williams-Hart et al. (2002) state that Glc7 itself 
might be regulating ion homeostasis through directly controlling ion transport and/or 
plasma membrane potential. However, in the same publication, when the ability of the 
glc7-109 mutant to grow on low K concentration conditions was tested, it grew equally 
to the wild type, suggesting that the increased sensitivity to LiCl and Hygromycin B is 
not due to a defect in K+ transporter.  As this mutant is clearly hyperpolarized, a more 
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direct determination of K+ transport should be made. In any case, these authors also 
stated that they could not find a direct involvement of Glc7 in Pma1 regulation. So we 
believe our results are in the same direction, where Glc7 does not affect Pma1 activity 
yet it affects ion sensitivity, which could be explained by the hypothesis that Glc7 
activates either K+ transport or an unknown mechanism of transport that affects ion 
homeostasis. Another explanation could be that because Glc7 is involved in 
dephosphorylation of S899 on glucose starvation (Mazón et al., 2015) which only 
affects the Pma1 Km, so the final effect on Pma1 activity is minor and is more apparent 
in terms of ion tolerance than “in vitro” assay with high ATP concentration.  To further 
complicate this issue, the “in vivo” assay of Pma1 activity by proton extrusion from 
cells is not only dependent on Pma1 activity but also influenced by K+ transport for 
electrical balance (Serrano, 1980; Bissoli et al., 2012). 
Because the regulatory subunits are responsible for Glc7 specificity (Luan 2003), 
it may be that a mutation of GLC7 affects its binding to certain regulatory subunits 
responsible for the enzyme binding to glycogen synthase but that such a mutation will 
have no effect on the enzyme activity on other substrates. Therefore it is very 
complicated to explain the glycogen defect and the different acetic acid and toxic cation 
sensitivity in the mutants. 
 
A plausible role for protein phosphatases in the activation of Pma1 by glucose 
metabolism 
 As discussed at the Introduction, protein phosphatases may be more than mere 
reset buttons of important phosphorylated proteins. The steady-state level of 
phosphorylation of important regulated proteins such as Pma1 could depend not only on 
the activity of the protein kinases but also on the relative activities of the kinases and 
phosphatases acting on the regulatory domain of the enzyme. The fact that these 
enzymes have not been identified by loss of function approaches suggests that they may 
be redundant or encode essential functions. As we have discarded the essential GLC7 
gene, a plausible mechanism for glucose activation could be that, in addition to 
activation of some protein kinases, phosphorylated metabolites derived from glucose 
cause a general inhibition of protein phosphatases. Although protein phosphatases have 
little specificity “in vitro” and are inhibited by many phosphorylated compounds, the 
situation “in vivo” is uncertain because the accessory subunits of the phosphatases put 
them in close proximity to their protein substrates. In any case, glucose induces in yeast 
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cells a dramatic increase in phosphorylated metabolites, reaching total values around 10 
mM (Gancedo and Gancedo, 1973) and therefore it is not unlikely that many protein 
phosphatases could be inhibited “in vivo” and contribute to activation of Pma1. This 
could explain the mysterious regulatory pathway of glucose requiring metabolism of the 
sugar  (Belinchón and Gancedo, 2007). 
 
Effect of expression of a dominant-negative form of GLC7 and of glucose 
metabolism on phosphorylation of eIF2α  
           The effect of the possible inhibition of Glc7 by glucose metabolites was 
investigated “in vivo” by measuring the phosphorylation level of eIF2α with specific 
antibody in wild type and in the GCN2c mutant, before and after addition of glucose. 
Figures 37 and 38 showed that glucose starvation led to decreased phosphorylation of 
eIF2α in the wild type.  These results differ from those of Castelli et al. (2011), who 
found that glucose starvation does not affect the levels of phosphorylated eIF2α. The 
experimental conditions, however, were different from ours because they worked with 
cells in rich YPD medium and then removed the glucose but kept all the other 
components of media while we resuspended cells in water with or without glucose. It 
would be interesting to determine what component of medium explains the differences 
in the results. 
 The decrease of eIF2α phosphorylation level in the wild type means that glucose 
starvation leads to either an increase of phosphatase activity or a decrease of the 
kinase’s one. Then checking the effect on a GCN2c mutant that has a constitutive 
hyperactivity of the kinase, we found out that there was no change of the 
phosphorylation level of eIF2α upon glucose starvation (Figure 38). This may suggest 
that the effect of glucose on eIF2α phosphorylation is mainly due to activation of Gcn2 
because when it was kept constant as in the GCN2c mutant there was no change of the 
phosphorylation level upon removal of glucose. However, the GCN2c mutant has a 
constitutive hyperactivity and this high effect might have masked the increase of Glc7 
activity under glucose starvation conditions. Therefore we believe that the hypothesis 
that glucose metabolism inhibits “in vivo” the activity of protein phosphatases such as 
Glc7 deserves further investigation. 
           In the strain expressing Glc7’ under doxycycline promoter there was no 
difference of the phosphorylation level of eIF2α before and after inducing the 
expression (Figure 39). The GLC7’ expression was confirmed by semiquantitative RT-
DISCUSSION 
 
	   86	  
PCR under the same conditions as mentioned before (Figure 31). However, in this 
experiment glucose was present and this may have already inhibited Glc7, making 
further inhibition by Glc7’ undetectable. Also, the experiment was done in minimal 
medium where Gcn2 is hyperactivated by the lack of amino acids. According to Wek et 
al. (1992) Glc7’ produces	   increased level of eIF2α phosphorylation in the gcn2-507 
mutant, with reduced activity of Gcn2. It maybe that an effect of Glc7’on eIF2α 
phosphorylation could only be seen in a defective mutant with decreased activity of 
Gcn2. 
Also in the same Figure 37 we have tested the different protein extraction 
methods in order to choose the best one for all the following experiments of western 
blotting and the results showed that the amount of protein produced by three different 
types of protein extraction (Laemmli, alkaline lysis and TCA) was so close unlike what 
was mentioned by (Wright et al., 1989). So we settled to the most convenient one, 
which is Laemmli method. 
 
Effect of sit4 null mutation on the activity of Pma1  
           Another important yeast phosphatase is Sit4, a major PP2A phosphatase. The sit4 
null mutant is viable so we used it to investigate the effect of Sit4 on Pma1. The 
phosphorylation level of Pma1 by using specific antibody against the double 
phosphorylation of SerT911 Thr912 (that is the major regulatory event by increasing the 
maximal activity of the enzyme, see Mazón et al., 2015) was less than that of the 
control strain after glucose activation (Figure 40). On the other hand, the mutant showed 
a decreased Pma1 activity “in vitro” and “in vivo” (Figures 41 and 42, respectively). 
These results together indicate that Sit4 is a positive regulator of Pma1 phosphorylation 
and activity.  
The effect of LiCl and hygromycin on the sit4 mutant was not clear (Figure 43). 
The growth of this mutant is much slower than that of control strain in normal 
conditions and therefore the effect of sit4 null mutation on tolerance to toxic cations 
was difficult to ascertain. 
 
 “In vitro” and “in vivo” effects of Glc7 and Sit4 on Pma1  
  It was possible to express active GST-Glc7 in the soluble fraction from E. coli 
(Figure 44). On the other hand, we made many trials to express GST-Sit4 in E. coli 
using several plasmids and growth conditions but we could never recover it in the 
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soluble fraction. Finally we could produce soluble and active GST-Sit4 by expression in 
yeast (Figure 46). GST-Glc7 and GST-Sit4 were purified, incubated with glucose-
activated Pma1 and finally the level of phosphorylation of Pma1 was checked with 
specific antibodies. Recombinant Glc7 dephosphorylated phospho-Ser899 (Figure 45) 
as suggested by Mazón et al. (2015). On the other hand, recombinant Sit4 
dephosphorylated the major activation site of Pma1 (double phosphorylation at Ser911 
Thr912; Figure 47).  
 The “in vitro” activity of protein phosphatases is not very specific because they 
depend  “in vivo” on regulatory subunits to target them to the different specific 
substrates (Luan, 2003). Therefore these experiments do not demonstrate that Glc7 and 
Sit4 act on Pma1 “in vivo”. Actually, our experiments on inhibition of Glc7 “in vivo” 
failed to demonstrate a participation of this phosphatase on the regulation of Pma1. It 
cannot be discarded, however, that the activating site of Pma1 was dephosphorylated by 
several redundant phosphatases and that Glc7 could be one of them. 
 On the other hand, the effect of the null mutation of Sit4 on Pma1 activity (“in 
vitro”, “in vivo” and phosphorylation level at the regulatory site, Ser911 Thr912) 
suggests that Sit4 promotes “in vivo” the phosphorylation of the activating site of Pma1 
instead of decreasing it as expected from a phosphatase. Therefore, instead of having a 
direct effect on Pma1 by dephosphorylation, Sit4 must act “in vivo” by an indirect 
mechanism to activate Pma1 by promoting the phosphorylation of its activating site. 
The nature of this mechanism is presently unknown but it could be related to the 
growth-promoting effect of Sit4. It can be speculated that Sit4 could dephosphorylate 
and activate a protein kinase acting on Pma1 or dephosphorylate and inactivate protein 
phosphatases acting on Pma1. 
 
TORC1 kinase is a positive regulator of Pma1 activity 
 
          The participation of TORC1 protein kinase in the regulation of Pma1 was 
investigated by two different mechanisms: using the specific TORC1 inhibitor 
(rapamycin) and increasing the temperature in a thermosensitive mutant of the TOR 
system.  
 Rapamycin treatment inhibited growth of yeast cells (Figure 48) because 
TORC1 is necessary for cell growth (Loewith and Hall, 2011). Pma1 activity showed a 
high decrease upon incubation with rapamycin, (Figure 49A) and there was a decrease 
on the phosphorylation level of the activation domain of Pma1 (Ser911 Thr912; Figure 
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49B).  This indicates that the TOR kinase is necessary for maximal activation of Pma1 
by glucose.  Such an effect could either be direct, TORC1 phosphorylating Pma1, or 
indirect by activating another kinase or inhibiting a phosphatase with negative effect on 
Pma1. The effect could also be a consequence of the inhibition of growth by rapamycin. 
Rapamycin treatment leads to inhibition of TORC1 and as a result to a G0 growth arrest 
within one generation (Barbet et al., 1996).  However, growth arrest by glucose 
deprivation does not affect the activation of Pma1 upon glucose addition (Serrano, 
1983). Another possibility could be a decrease in Pma1 amount. Rapamycin treatment 
causes high drop in protein synthesis by blocking translation initiation (Barbet et al., 
1996). Such an explanation could not be used to justify the decrease in Pma1 activity in 
terms of decreased protein synthesis because according to Benito et al., (1990) the half 
life of Pma1 under our experimental conditions (presence of glucose and exponential 
phase culture) is more than 20 hours while the decrease in activity in our experiment 
was detected after just 2 hours, so clearly this is not the explanation. Accordingly, we 
did not observe a decrease in Pma1 protein levels measured with antibodies against the 
whole enzyme during the rapamycin treatment (Figure 49B). 
          Another way to inhibit TORC1 is by using a non-permissive temperature with a 
thermosensitive mutant of this essential protein kinase. Mutant SH221 (tor1 tor2-21ts) is 
temperature sensitive for both TOR complexes and functions (activation of translation 
initiation of TORC1 and the organization of the actin cytoskeleton of TORC2), 
although only TORC1 is sensitive to rapamycin (Helliwell et al., 1998). Its growth was 
normal at room temperature but defective at 37ºC as expected from inhibition of TOR 
(Figure 50). Accordingly, incubation at the non-permissive temperature reduced the 
activity of Pma1 and the phosphorylation of Ser911 Thr912 in this mutant with no 
effect on the control strain (Figure 51). 
According to Helliwell et al. (1998) loss of TOR1 and TOR2 functions causes 
arrest in the early G1 phase of the cell cycle, like rapamycin treatment does (Barbet et 
al., 1996) and the arrested cells show characteristics of starved cells in stationary phase 
(G0), glycogen accumulation and a decrease in protein synthesis. The block in protein 
synthesis happens at the level of initiation and is the cause of the cell cycle arrest. TOR2 
overlaps with TOR1 and mediates protein synthesis and cell cycle progression through 
the G1 phase of the cell cycle in response to nutrients (Barbet et al., 1996). 
 We have observed that in order to detect the effect of TOR on Pma1 activity 
cells must be in exponential phase, because at the beginning we tried treatment of 
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rapamycin on cells in stationary phase and this did not lead to change of Pma1 activity, 
probably because TORC1 activity is already decreased in this phase due to lack of 
nutrients (Galdieri et al., 2010). 
 Another practical point refers to the fact that although 10-100 nM rapamycin 
was enough to inhibit growth of inoculated cultures, in grown cultures with much 
higher cell density, these concentrations of rapamycin had no effect on Pma1 activity 
(Figure 48). We then considered that when working with hydrophobic inhibitors such as 
rapamycin there should be an increase in inhibitor concentration when the cell 
concentration is increased. With cells in late exponential phase and during the glucose 
activation step before cell homogenization the concentration of yeast is much higher 
than in inoculated cultures at the beginning of growth. When rapamycin was added to 
the cells at higher concentration (10 µM) keeping the rapamycin to cells ratio, the effect 
on Pma1 activity was noticed. 
           The decrease of Pma1 activity after rapamycin treatment was higher than that 
obtained when TOR was inhibited in the thermosensitive mutant SH221 by incubation 
at the non-permissive temperature (activity decreased to 45% and 65% of control, 
respectively). This could mean that the effect on Pma1 of the high concentrations of 
rapamycin employed may have additional targets other than TORC1 or that the non-
permissive temperature does not fully inhibits TORC1. 
           Because Sit4 increased Pma1 activity and rapamycin decreased it, and knowing 
that TORC1 inactivation results in Tap42 weakened association with phosphatases (Yan 
et al., 2006), so probably Sit4 needs the binding with Tap42 in its pathway to activate 
Pma1.  
Our finding that both TORC1 and Sit4 are required for full activation of Pma1 is 
in agreement with the finding that Sit4 acts downstream of TORC1 for many important 
physiological functions, including nutrient sensing for growth control (Rhode et al., 
2004; Loewith and Hall, 2011), a function also contributed by Pma1, activated by 
glucose and determining growth rate (Serrano, 1983: Portillo and Serrano 1989). 
Recently it has been reported that Pma1 activation increases intracellular pH and 
this activates TORC1 (Dechant et al., 2014). Together with our results this suggest that 
there is cross activation between TORC1 and Pma1, the two cellular systems 
responding to nutrients. TORC1 is mostly activated by amino acids while Pma1 is 
mostly activated by sugar metabolism and therefore it makes sense that there is cross 
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  CONCLUSIONS  
The objectives of the present thesis were: 
 
1- Determine if Glc7, the major PP1 protein phosphatase of yeast and also implicated 
 in ion homeostasis, has a role in the activation of yeast plasma membrane H+-
 ATPase (Pma1) by glucose 
2- Determine if Sit4, a PP2A protein phosphatase implicated in yeast growth, has a 
 role in the activation of Pma1 by glucose 
3- Investigate the participation of the growth-promoting protein kinase TORC1 in the 
 activation of Pma1 by glucose 
 
And the conclusions are: 
 
1- Inhibition “in vivo” of Glc7 results in neither increased activity of Pma1 nor 
increased phosphorylation of the major regulatory site (Ser911 Thr912) in the 
presence of glucose metabolism. However, in the glc7-1 and glc7-132 mutants 
acetic acid tolerance and Pma1 activity are increased. Glc7 may be involved in 
regulation of Pma1 but with only a minor effect and other protein phosphatases 
are redundant with it. 
 
2- Glc7 itself might be regulating ion homeostasis through directly controlling ion 
transport and/or plasma membrane potential or an unknown mechanism of 
transport that affects ion homeostasis. 
	  
3- Protein phosphatase Sit4 can dephosphorylate “in vitro” the regulatory site of the 
 glucose-activated form of Pma1. However, deletion of the SIT4 gene results in 
 decreased phosphorylation of the regulatory site and decreased activity of Pma1 
 in the presence of glucose metabolism. Therefore Sit4 activates “in vivo” Pma1 
 by an indirect mechanism instead of inactivating it by direct 
 dephosphorylation. This activation may contribute to the activation of growth 
 and proliferation by this phosphatase 
4- Inhibition of protein kinase TORC1 results in decreased phosphorylation of the 
regulatory site and decreased activity of Pma1 in the presence of glucose 
metabolism. Activation of Pma1 by TORC1 maybe direct or through     
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